Document:

Exhibit 10.5

 

 

 

 

FLY BLADE, INC.

 

AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT

 

January 30, 2018

 

    

     

    

 

TABLE OF CONTENTS

 

	 	 	Page
	Section 1 Definitions	1
	 	 
	1.1	Certain Definitions	1
	 	 	 
	Section 2 Registration Rights	4
	 	 
	2.2	Company
    Registration	6
	2.3	Registration on Form S-3	7
	2.4	Expenses
    of Registration	8
	2.5	Registration
    Procedures	8
	2.6	Indemnification	10
	2.7	Information
    by Investor	11
	2.8	Restrictions
    on Transfer	11
	2.9	Rule 144 Reporting	13
	2.10	Market Stand -Off Agreement	14
	2.11	Delay
    of Registration	14
	2.12	Transfer
    or Assignment of Registration Rights	14
	2.13	Limitations
    on Subsequent Registration Rights	14
	2.14	Termination
    of Registration Rights	14
	 	 	 
	Section 3 Covenants	14
	 	 
	3.1	Basic
    Financial Information and Inspection Rights	14
	3.2	Confidentiality	15
	3.3	“Bad
    Actor” Notice	16
	3.4	Board
    Matters	16
	3.5	Observation
    Rights	16
	3.6	Directors
    and Officers Insurance	16
	3.7	Successor
    Indemnification	16
	3.8	Termination
    of Covenants	16
	 	 	 
	Section 4 Right of First Refusal	17
	 	 
	4.1	Right of First Refusal to Investors	17
	 	 	 
	Section 5 Miscellaneous	18
	 	 
	5.1	Amendment	18
	5.2	Notices	18
	5.3	Governing
    Law	19
	5.4	Successors
    and Assigns	19
	5.5	Entire
    Agreement	19
	5.6	Delays
    or Omissions	19
	5.7	Severability	19
	5.8	Titles
    and Subtitles	19
	5.9	Counterparts	20
	5.10	Telecopy Execution and Delivery	20
	5.11	Jurisdiction;
    Venue	20
	5.12	Further
    Assurances	20
	5.13
    	Termination
    Upon Change of Control	20
	5.14	Conflict	20

 

    -i-

     

    

 

TABLE OF CONTENTS

(continued)

 

	 	 	Page
	5.15	Attorneys’ Fees	20
	5.16	Aggregation of Stock	20
	5.17	Jury Trial	21
	5.18	Right to Conduct Activities	21

 

    -ii-

     

    

 

FLY BLADE, INC.

AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT

 

This
Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of January 30,
2018 and is between Fly Blade, Inc., a Delaware corporation (the “Company”), and the persons and
entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).

 

RECITALS

 

WHEREAS,
the Company, and certain of the Investors (the “Prior Investors”) previously entered into an Amended
and Restated Investors’ Rights Agreement, dated May 3, 2016 (as amended from time to time, the “Prior Agreement”),
in connection with the Company’s issuance and sale of shares of Series A Preferred Stock (as defined below).

 

WHEREAS,
the Company and certain of the Investors are parties to the Series B Preferred Stock Purchase Agreement (as amended from time
to time, the “Purchase Agreement”), dated as of the date hereof, among the Company and such Investors,
and it is a condition to the closing of the transactions contemplated thereby that the Company and the Investors execute and deliver
this Agreement.

 

WHEREAS,
the Company and the Prior Investors intend that the Prior Agreement shall be superseded and replaced in its entirety by this Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, the Company and the Investors holding a sufficient number of shares of the Company’s capital stock hereby
agree to amend and restate the Prior Agreement in its entirety as set forth herein, and the parties hereto agree as follows:

 

SECTION 1

 

DEFINITIONS

 

		1.1	Certain Definitions. As used in this Agreement, the following terms shall have the meanings set forth below:

 

(a)          “Affiliate”
means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under
common control with such Person, including without limitation any general partner, managing member, officer or director of such
Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members
of, or shares the same management company with, such Person.

 

 (b)          “Bad Actor Disqualification” means any “bad actor” disqualification described in Rule 506(d)(1)(i) through (viii) under the Securities Act.

 

		(c)	“Board” means the Company’s Board of Directors.

 

		(d)	“Change of Control” has the meaning set forth in Section 5.13.

 

		(e)	“Closing” has the meaning set forth in the Purchase Agreement.

 

    

     

    

 

(f)           “Commission”
means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

		(g)	“Common Stock” means the Common Stock of the Company.

 

(h)           “Competitor”
means a Person engaged, directly or indirectly (including through any partnership, limited liability company, corporation, joint
venture or similar arrangement (whether now existing or formed hereafter)), that is in the business of transporting paying passengers
by air, but shall not include any Person, together with its Affiliates, who holds less than twenty percent (20)% of the outstanding
equity of any Competitor and does not, nor do any of its Affiliates, have a right to designate any members of the Board of Directors
of any Competitor.

 

(i)            “Conversion
Stock” means shares of Common Stock issued upon conversion of the Series Seed Preferred Stock.

 

(j)            “Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the rules and
regulations thereunder, all as the same shall be in effect from time to time.

 

(k)           “Initial
Public Offering” means the closing of the Company’s first firm commitment underwritten public offering of the
Company’s Common Stock registered under the Securities Act.

 

(l)            “Initiating
Investors” means Investors who in the aggregate hold a majority of the outstanding Registrable Securities.

 

(m)          “Investors”
means the persons and entities listed on Exhibit A and any holder of shares of Preferred Stock to whom the rights conferred
by this Agreement have been duly and validly transferred in accordance with Section 2 of this Agreement.

 

(n)           “Liquidation
Event” means any liquidation, dissolution or winding up of the Company, including a Deemed Liquidation Event (as
defined in Section 3(d) of the Restated Certificate).

 

(o)           “Major
Investor” means any Investor who holds shares of Preferred Stock with an aggregate initial purchase price from the
Company of at least $499,995 and who is not a competitor as determined by a Special Board Vote (as defined in the Restated Certificate).

 

		(p)	“New Securities” has the meaning set forth in Section 4.1(a).

 

		(q)	“Notes” has the meaning set forth in the Purchase Agreement.

 

(r)            “Person”
means any individual, corporation, partnership, trust, limited liability company, association or other entity.

 

(s)           “Preferred
Director” means the member of the Board that the holders of Series Seed Preferred Stock and Series A Preferred
Stock, voting together as a single class, are entitled to elect pursuant to the Restated Certificate.

 

(t)           “Preferred
Stock” means, collectively, the Series Seed Preferred Stock, the Series A Preferred Stock and the Series B
Preferred Stock.

 

		(u)	“Purchase Agreement” has the meaning set forth in the Recitals.

 

    -2-

     

    

 

(v)          “Qualified
Investor” means any Investor who holds shares of Preferred Stock with an aggregate initial purchase price from the
Company of at least $249,995.

 

		(w)	“Qualified IPO” has the meaning set forth in the Restated Certificate.

 

(x)           “Registrable
Securities” means (i) shares of Common Stock issued or issuable pursuant to the conversion of the Preferred
Stock and (ii) any Common Stock issued as a dividend or other distribution with respect to or in exchange for or in replacement
of the shares referenced in (i) above; provided, however, that Registrable Securities shall not include any shares of Common
Stock described in clauses (i) or (ii) above which have previously been registered or which have been sold to the public
either pursuant to a registration statement or Rule 144, or which have been sold in a private transaction in which the transferor’s
rights under this Agreement are not validly assigned in accordance with this Agreement.

 

(y)          “Registration
Expenses” means all expenses incurred in effecting any registration pursuant to this Agreement, including, without
limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees and disbursements of counsel
for the Company and one special counsel for the Investors, blue sky fees and expenses, and expenses of any regular or special audits
incident to or required by any such registration, but shall not include Selling Expenses, fees and disbursements of other counsel
for the Investors and the compensation of regular employees of the Company, which shall be paid in any event by the Company.

 

(z)            The
terms “register,” “registered” and “registration”
refers to a registration effected by preparing and filing a registration statement in compliance with the Securities Act and applicable
rules and regulations thereunder, and the declaration or ordering of the effectiveness of such registration statement.

 

		(aa)	“Restated Certificate” means
the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time.

 

(bb)
        “Restricted Securities” means any shares of Preferred Stock required to bear the first legend set forth
in Section 2.8(c).

 

(cc)
        “Rule 144” means Rule 144 as promulgated by the Commission under the Securities Act, as such
Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

 

(dd)
        “Securities Act” means the Securities Act of 1933, as amended, or any similar successor federal statute
and the rules and regulations thereunder, all as the same shall be in effect from time to time.

 

(ee)
        “Selling Expenses” means all underwriting discounts, selling commissions and stock transfer taxes applicable
to the sale of Registrable Securities and fees and disbursements of counsel for any Investor (other than the fees and disbursements
of one special counsel to the Investors included in Registration Expenses).

 

(ff)          “Series A
Preferred Stock” means the shares of the Company’s Series A Preferred Stock.

 

(gg)        “Series B
Director” means the member of the Board that the holders of Series B Preferred Stock are entitled to elect pursuant
to the Restated Certificate.

 

    -3-

     

    

 

(hh)        “Series B
Preferred Stock” means the shares of the Company’s Series B Preferred Stock.

 

(ii)          “Series Seed
Preferred Stock” means the shares of the Company’s Series Seed Preferred Stock.

 

SECTION 2

 

REGISTRATION
RIGHTS

 

		2.1	Requested Registration.

 

(a)           Request
for Registration. Subject to the conditions set forth in this Section 2.1, if the Company shall receive from
Initiating Investors a written request signed by such Initiating Investors that the Company effect any registration with respect
to all or a part of the Registrable Securities (such request shall state the number of shares of Registrable Securities to be disposed
of by such Initiating Investors), the Company will:

 

 (i)             promptly give written notice of the proposed registration to all other Investors; and

 

(ii)            as
soon as practicable, file and use its commercially reasonable efforts to effect such registration (including, without limitation,
filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws, and appropriate
compliance with the Securities Act) and to permit or facilitate the sale and distribution of all or such portion of such Registrable
Securities as are specified in such request, together with all or such portion of the Registrable Securities of any Investor or
Investors joining in such request as are specified in a written request received by the Company within 20 days after such written
notice from the Company is mailed or delivered.

 

(b)           Limitations
on Requested Registration. The Company shall not be obligated to effect, or to take any action to effect, any such registration
pursuant to this Section 2.1:

 

(i)             Prior
to the earlier of (A) the five (5) year anniversary of the date of this Agreement or (B) one hundred and eighty
(180) days following the effective date of the first Qualified IPO (or the subsequent date on which all market stand-off agreements
applicable to the offering have terminated);

 

(ii)            If
the Initiating Investors, together with the holders of any other securities of the Company entitled to inclusion in such registration
statement, propose to sell Registrable Securities and such other securities (if any) the aggregate proceeds of which (after deduction
for underwriter’s discounts and expenses related to the issuance) are less than $10,000,000;

 

(iii)           In
any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting
such registration, qualification, or compliance, unless the Company is already subject to service in such jurisdiction and except
as may be required by the Securities Act;

 

(iv)           After
the Company has initiated two such registrations pursuant to this Section 2.1 (counting for these purposes only registrations
which have been declared or ordered effective and pursuant to which securities have been sold);

 

    -4-

     

    

 

(v)            During
the period starting with the date 60 days prior to the Company’s good faith estimate of the date of filing of; provided
the Company provides the holders of Registrable Securities notice of such filing within 30 days after the Company has received
notice from the Initiating Investors pursuant to Section 2.1(a); and ending on a date 180 days after the effective
date of, a Company-initiated registration; provided that the Company is actively employing in good faith commercially reasonable
efforts to cause such registration statement to become effective;

 

(vi)           If
the Initiating Investors propose to dispose of shares of Registrable Securities that may be registered on Form S-3 pursuant
to a request made under Section 2.3; and

 

(vii)          If
the Company and the Initiating Investors are unable to obtain the commitment of the underwriter described in Section 2.1(e) to
firmly underwrite the offer.

 

(c)           Deferral.
If (i) in the good faith judgment of the Board, the filing of a registration statement covering the Registrable Securities
would be materially detrimental to the Company and the Board concludes, as a result, that it is in the best interests of the Company
to defer the filing of such registration statement at such time, and (ii) the Company shall furnish to such Investors a certificate
signed by the President of the Company stating that in the good faith judgment of the Board, it would be materially detrimental
to the Company for such registration statement to be filed in the near future and that it is, therefore, in the best interests
of the Company to defer the filing of such registration statement, then (in addition to the limitations set forth in Section 2.1(b)(v) above)
the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request
of the Initiating Investors, and, provided further, that the Company shall not defer its obligation in this manner more
than twice in any twelve-month period.

 

(d)           Other
Shares. The registration statement filed pursuant to the request of the Initiating Investors may, subject to the provisions
of Section 2.1(e), include other securities, and may include securities of the Company being sold for the account of
the Company.

 

(e)           Underwriting.
The right of any Investor to include all or any portion of its Registrable Securities in a registration pursuant to this
Section 2.1 shall be conditioned upon such Investor’s participation in an underwriting and the inclusion of such
Investor’s Registrable Securities to the extent provided herein. If the Company shall request inclusion in any registration
pursuant to Section 2.1 of securities being sold for its own account, or if other persons shall request inclusion in
any registration pursuant to Section 2.1, the Initiating Investors shall, on behalf of all Investors, offer to include
such securities in the underwriting and such offer shall be conditioned upon the participation of the Company or such other persons
in such underwriting and the inclusion of the Company’s and such person’s other securities of the Company and their
acceptance of the further applicable provisions of this Section 2 (including Section 2.10). The Company
shall (together with all Investors and other persons proposing to distribute their securities through such underwriting) enter
into an underwriting agreement in customary form with the representative of the underwriter or underwriters selected for such underwriting
by the Company, which underwriters are subject to the approval of a majority-in-interest of the Initiating Investors (such approval
not to be unreasonably withheld, conditioned or delayed).

 

Notwithstanding
any other provision of this Section 2.1, if the underwriters advise the Initiating Investors in writing that
marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Investors shall so
advise all Investors of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of
Registrable Securities that may be included in the underwriting shall be allocated among such Investors of Registrable
Securities, including the Initiating Investors, in proportion (as nearly as practicable) to the number of Registrable
Securities owned by each Investor or in such other proportion as shall mutually be agreed to by all such selling Investors;
provided, however, that (i) the number of Registrable Securities held by the Investors to be included in such
underwriting shall not be reduced unless all other securities (other than the securities sold on behalf of the Company) are
first entirely excluded from the underwriting, and (ii) the number of Registrable Securities included in the offering
shall not be reduced below twenty-five percent (25%) of the total number of securities included in such offering, unless such
offering is a Qualified IPO, in which case the selling Investors may be excluded further if the underwriters make the
determination described above and no other stockholder’s securities are included in such offering.

 

    -5-

     

    

 

If
a person who has requested inclusion in such registration as provided above does not agree to the terms of any such underwriting,
such person shall be excluded therefrom by written notice from the Company, the underwriter or the Initiating Investors. The securities
so excluded shall also be withdrawn from registration. Any Registrable Securities or other securities excluded or withdrawn from
such underwriting shall also be withdrawn from such registration.

 

		2.2	Company Registration.

 

(a)           Company
Registration. If the Company shall determine to register any of its securities either for its own account or the account
of a security holder or holders, other than a registration pursuant to Section 2.3, a registration relating solely
to employee benefit plans, a registration relating to the offer and sale of debt securities, a registration relating to a corporate
reorganization or other Rule 145 transaction, or a registration on any registration form that does not permit secondary sales,
the Company will:

 

 (i)             promptly give written notice of the proposed registration to all Investors; and

 

(ii)            use
its commercially reasonable efforts to include in such registration (and any related qualification under blue sky laws or other
compliance), except as set forth in Section 2.2(b) below, and in any underwriting involved therein, all of such
Registrable Securities as are specified in a written request or requests made by any Investor or Investors received by the Company
within ten (10) days after such written notice from the Company is mailed or delivered. Such written request may specify all
or a part of an Investor’s Registrable Securities.

 

(b)            Underwriting.
If the registration of which the Company gives notice is for a registered public offering involving an underwriting, the
Company shall so advise the Investors as a part of the written notice given pursuant to Section 2.2(a)(i). In such
event, the right of any Investor to registration pursuant to this Section 2.2 shall be conditioned upon such Investor’s
participation in such underwriting and the inclusion of such Investor’s Registrable Securities in the underwriting to the
extent provided herein. All Investors proposing to distribute their securities through such underwriting shall (together with the
Company and other holders of securities of the Company with registration rights to participate therein distributing their securities
through such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or
underwriters selected by the Company.

 

Notwithstanding
any other provision of this Section 2.2, if the underwriters advise the Company in writing that marketing factors
require a limitation on the number of shares to be underwritten, then the Company shall so advise all Investors of
Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that
may be included in the underwriting shall be allocated among such Investors of Registrable Securities in proportion (as
nearly as practicable) to the number of Registrable Securities owned by each Investor or in such other proportion as shall
mutually be agreed to by all such selling Investors; provided, however, that (i) the number of Registrable Securities
held by the Investors to be included in such underwriting shall not be reduced unless all other securities (other than the
securities sold on behalf of the Company) are first entirely excluded from the underwriting and (ii) the number of
Registrable Securities included in the offering shall not be reduced below twenty-five percent (25%) of the total number of
securities included in such offering, unless such offering is a Qualified IPO, in which case the selling Investors may be
excluded further if the underwriters make the determination described above and no other stockholder’s securities are
included in such offering.

 

    -6-

     

    

 

If
a person who has requested inclusion in such registration as provided above does not agree to the terms of any such underwriting,
such person shall also be excluded therefrom by written notice from the Company or the underwriter. The Registrable Securities
or other securities so excluded shall also be withdrawn from such registration. Any Registrable Securities or other securities
excluded or withdrawn from such underwriting shall be withdrawn from such registration.

 

(c)           Right
to Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under
this Section 2.2 prior to the effectiveness of such registration whether or not any Investor has elected to include
securities in such registration.

 

		2.3	Registration on Form S-3.

 

(a)           Request
for Form S-3 Registration. After the Initial Public Offering, the Company shall use its commercially reasonable efforts
to qualify for registration on Form S-3 or any comparable or successor form or forms. After the Company has qualified for
the use of Form S-3, in addition to the rights contained in the foregoing provisions of this Section 2 and subject
to the conditions set forth in this Section 2.3, if the Company shall receive from an Investor or Investors of Registrable
Securities a written request that the Company effect any registration on Form S-3 or any similar short form registration statement
with respect to all or part of the Registrable Securities (such request shall state the number of shares of Registrable Securities
to be disposed of and the intended methods of disposition of such shares by such Investor or Investors), the Company will take
such action as required by Sections 2.2(a)(i) and 2.2(a)(ii).

 

(b)           Limitations
on Form S-3 Registration. The Company shall not be obligated to effect, or take any action to effect, any such registration
pursuant to this Section 2.3:

 

(i)             Prior
to one hundred eighty (180) days following the effective date of the first registration statement filed by the Company covering
an underwritten offering of any of its securities to the general public (or the subsequent date on which all market stand-off agreements
applicable to the offering have terminated);

 

(ii)            If
the Investors, together with the holders of any other securities of the Company entitled to inclusion in such registration statement,
propose to sell Registrable Securities and such other securities (if any) the aggregate proceeds of which are less than $1,000,000;
or

 

(iii)            If,
in a given twelve-month period, the Company has effected two (2) such registrations in such period.

 

(c)           Deferral. If
(i) in the good faith judgment of the Board, the filing of a registration statement covering the Registrable Securities
would be materially detrimental to the Company and the Board concludes, as a result, that it is in the best interests of the
Company to defer the filing of such registration statement at such time, and (ii) the Company shall furnish to such
Investors a certificate signed by the President of the Company stating that in the good faith judgment of the Board, it would
be materially detrimental to the Company for such registration statement to be filed in the near future and that it is,
therefore, in the best interests of the Company to defer the filing of such registration statement, then (in addition to the
limitations set forth in Section 2.3(b)(iii) above) the Company shall have the right to defer such filing
for a period of not more than ninety (90) days after receipt of the request of the Initiating Investors, and, provided
further, that the Company shall not defer its obligation in this manner more than once in any twelve-month period.

 

    -7-

     

    

 

(d)           Underwriting.
If the Investors of Registrable Securities requesting registration under this Section 2.3 intend to distribute
the Registrable Securities covered by their request by means of an underwriting, the provisions of Section 2.2(b) shall
apply to such registration.

 

2.4           Expenses
of Registration. All Registration Expenses incurred in connection with registrations pursuant to Sections 2.1, 2.2
and 2.3 shall be borne by the Company; provided, however, that the Company shall not be required to pay
for any expenses of any registration proceeding begun pursuant to Sections 2.1 and 2.3 if the registration request
is subsequently withdrawn at the request of the Investors of a majority of the Registrable Securities to be registered or because
a sufficient number of Investors shall have withdrawn so that the minimum offering conditions set forth in Sections 2.1 and
2.3 are no longer satisfied (in which case all participating Investors shall bear such expenses pro rata among each
other based on the number of Registrable Securities requested to be so registered), unless, with respect to a registration pursuant
to Section 2.1, the holders of a majority of the Registrable Securities agree to forfeit their right to a demand registration;
provided, however, in the event that a withdrawal by the Investors is based upon adverse information relating to
the Company that is different from the information known or available (upon request from the Company or otherwise) to the Investors
requesting registration at the time of their request for registration under Section 2.1, the Company shall be required
to pay such expenses of registration and such registration shall not be treated as a counted registration for purposes of Sections
2.1. All Selling Expenses relating to securities registered on behalf of the Investors shall be borne by the holders of securities
included in such registration pro rata among each other on the basis of the number of Registrable Securities so registered.

 

2.5           Registration
Procedures. In the case of each registration effected by the Company pursuant to Section 2, the Company will keep
each Investor advised in writing as to the initiation of each registration and as to the completion thereof. At its expense, the
Company will use its commercially reasonable efforts to:

 

(a)           Keep
such registration effective for a period ending on the earlier of the date which is sixty (60) days from the effective date of
the registration statement or such time as the Investor or Investors have completed the distribution described in the registration
statement relating thereto;

 

(b)           To
the extent the Company is a well-known seasoned issuer (as defined in Rule 405 under the Securities Act) (a “WKSI”)
at the time any request for registration is submitted to the Company in accordance with Section 2.3, (i) if so
requested, file an automatic shelf registration statement (as defined in Rule 405 under the Securities Act) (an “automatic
shelf registration statement”) to effect such registration, and (ii) remain a WKSI (and not become an ineligible
issuer (as defined in Rule 405 under the Securities Act)) during the period during which such automatic shelf registration
statement is required to remain effective in accordance with this Agreement;

 

(c)           Prepare
and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement for the period set forth in subsection (a) above;

 

(d)           Furnish
such number of prospectuses, including any preliminary prospectuses, and other documents incident thereto, including any amendment
of or supplement to the prospectus, as an Investor from time to time may reasonably request;

 

    -8-

     

    

 

(e)           Use
its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities
or Blue Sky laws of such jurisdiction as shall be reasonably requested by the Investors; provided, that the Company shall
not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service
of process in any such states or jurisdictions;

 

(f)            Notify
each seller of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in
such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances
then existing, and following such notification promptly prepare and furnish to such seller a reasonable number of copies of a supplement
to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such
prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing;

 

(g)           Use
its commercially reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters
for sale, if such securities are being sold through underwriters,

 

(i)             an
opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance
as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and reasonably
satisfactory to a majority in interest of the Investors requesting registration of Registrable Securities and (ii) a “comfort”
letter dated as of such date, from the independent certified public accountants of the Company, in form and substance as is customarily
given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters;

 

(h)            In
connection with any underwritten offering pursuant to a registration statement filed pursuant to Section 2.1, enter
into an underwriting agreement in form reasonably necessary to effect the offer and sale of Common Stock, provided such underwriting
agreement contains reasonable and customary provisions, and provided further, that each Investor participating in such underwriting
shall also enter into and perform its obligations under such an agreement.

 

(i)            Provide
a transfer agent and registrar for all Registrable Securities registered pursuant to such registration statement and a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration; and

 

(j)            Cause
all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed.

 

    -9-

     

    

 

		2.6	Indemnification.

 

(a)            To
the extent permitted by law, the Company will indemnify and hold harmless each Investor, each of its officers, directors and
partners, legal counsel and accountants and each person controlling such Investor within the meaning of Section 15 of
the Securities Act, with respect to which registration, qualification or compliance has been effected pursuant to this Section 2,
and each underwriter, if any, and each person who controls within the meaning of Section 15 of the Securities Act any
underwriter, against all expenses, claims, losses, damages and liabilities (or actions, proceedings or settlements in respect
thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained
or incorporated by reference in any prospectus, offering circular or other document (including any related registration
statement, notification or the like) incident to any such registration, qualification or compliance
(ii) any omission (or alleged omission) to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or
(iii) any violation (or alleged violation) by the Company of the Securities Act, any state securities laws or any
rule or regulation thereunder applicable to the Company and relating to action or inaction required of the Company in
connection with any offering covered by such registration, qualification or compliance, and the Company will reimburse each
such Investor, each of its officers, directors, partners, legal counsel and accountants and each person controlling such
Investor, each such underwriter and each person who controls any such underwriter, for any legal and any other expenses
reasonably incurred in connection with investigating and defending or settling any such claim, loss, damage, liability or
action; provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage,
liability, or action arises out of or is based on any untrue statement or omission based upon written information furnished
to the Company by such Investor, any of such Investor’s officers, directors, partners, legal counsel or accountants,
any person controlling such Investor, such underwriter or any person who controls any such underwriter, and stated to be
specifically for use therein; and provided, further that, the indemnity agreement contained in this Section 2.6(a) shall
not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably withheld).

 

(b)           To
the extent permitted by law, each Investor will, if Registrable Securities held by such Investor are included in the securities
as to which such registration, qualification or compliance is being effected, indemnify and hold harmless the Company, each of
its directors, officers, partners, legal counsel and accountants and each underwriter, if any, of the Company’s securities
covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15
of the Securities Act, each other such Investor, and each of their officers, directors and partners, and each person controlling
each other such Investor, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or
based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference
in any prospectus, offering circular or other document (including any related registration statement, notification, or the like)
incident to any such registration, qualification or compliance, or (ii) any omission (or alleged omission) to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the
Company and such Investors, directors, officers, partners, legal counsel and accountants, persons, underwriters, or control persons
for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage,
liability or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement)
or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance
upon and in conformity with written information furnished to the Company by such Investor and stated to be specifically for use
therein; provided, however, that the obligations of such Investor hereunder shall not apply to amounts paid in settlement
of any such claims, losses, damages or liabilities (or actions in respect thereof) if such settlement is effected without the consent
of such Investor (which consent shall not be unreasonably withheld); and provided that in no event shall any indemnity under
this Section 2.6 exceed the net proceeds from the offering received by such Investor, except in the case of fraud or
willful misconduct by such Investor.

 

(c)           Each
party entitled to indemnification under this Section 2.6 (the “Indemnified Party”)
shall give notice to the party required to provide indemnification (the “Indemnifying Party”)
promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit
the Indemnifying Party to assume the defense of such claim or any litigation resulting therefrom; provided that
counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation resulting therefrom, shall
be approved by the Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may
participate in such defense at such party’s expense; and provided further that the failure of any Indemnified
Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.6,
to the extent such failure is not prejudicial. No Indemnifying Party, in the defense of any such claim or litigation, shall,
except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release
from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding
itself or the claim in question as an Indemnifying Party may reasonably request in writing and as shall be reasonably
required in connection with defense of such claim and litigation resulting therefrom.

 

    -10-

     

    

 

(d)           If
the indemnification provided for in this Section 2.6 is held by a court of competent jurisdiction to be unavailable
to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to herein, then the Indemnifying
Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative
fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or
omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations.
The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information
supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information,
and opportunity to correct or prevent such statement or omission. No person or entity will be required under this Section 2.6(d) to
contribute any amount in excess of the net proceeds from the offering received by such person or entity, except in the case of
fraud or willful misconduct by such person or entity. No person or entity guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty
of such fraudulent misrepresentation.

 

(e)           Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

 

2.7           Information
by Investor. Each Investor of Registrable Securities shall furnish to the Company such information regarding such Investor
and the distribution proposed by such Investor as the Company may reasonably request in writing and as shall be reasonably required
in connection with any registration, qualification, or compliance referred to in this Section 2.

 

		2.8	Restrictions on Transfer.

 

(a)           The
holder of each certificate representing Restricted Securities by acceptance thereof agrees to comply in all respects with the provisions
of this Section 2.8 Each Investor agrees not to make any sale, assignment, transfer, pledge or other disposition of
all or any portion of the Restricted Securities, or any beneficial interest therein, unless and until the transferee thereof has
agreed in writing for the benefit of the Company to take and hold such Restricted Securities subject to, and to be bound by, the
terms and conditions set forth in this Agreement, including, without limitation, this Section  2.8 and Section 2.10
and:

 

(i)            There
is then in effect a registration statement under the Securities Act covering such proposed disposition and the disposition is made
in accordance with the registration statement; or

 

    -11-

     

    

 

(ii)            The
Investor shall have given prior written notice to the Company of the Investor’s intention to make such disposition and
shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition,
and, if requested by the Company, the Investor shall have furnished the Company, at the Investor’s expense, with
(i) an opinion of counsel reasonably satisfactory to the Company to the effect that such disposition will not require
registration of such Restricted Securities under the Securities Act or (ii) a “no action” letter from the
Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the
staff of the Commission that action be taken with respect thereto, whereupon the holder of such Restricted Securities shall
be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the Investor to
the Company. It is agreed that the Company will not require opinions of counsel for transactions made pursuant to
Rule 144 except in unusual circumstances.

 

(b)            Notwithstanding
the provisions of Section 2.8(a), no such registration statement or opinion of counsel or “no action” letter
shall be necessary for (i) a transfer not involving a change in beneficial ownership, or (ii) transactions involving
the distribution without consideration of Restricted Securities by any Investor to (x) a parent, subsidiary or other affiliate
of the Investor, if the Investor is a corporation, (y) any of the Investor’s partners, members or other equity owners,
or retired partners, retired members or other equity owners, or to the estate of any of the Investor’s partners, members
or other equity owners or retired partners, retired members or other equity owners, or (z) a venture capital fund that is
controlled by or under common control with one or more general partners or managing members of, or shares the same management company
with, the Investor; provided, in each case, that the Investor shall give written notice to the Company of the Investor’s
intention to effect such disposition and shall have furnished the Company with a detailed description of the manner and circumstances
of the proposed disposition.

 

(c)            Each
certificate representing Registrable Securities shall (unless otherwise permitted by the provisions of this Agreement) be stamped
or otherwise imprinted with a legend substantially similar to the following (in addition to any legend required under applicable
state securities laws):

 

THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER
THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE
ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR
TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO (1) RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE
EVENT OF A PUBLIC OFFERING, AS SET FORTH IN AN INVESTORS’ RIGHTS AGREEMENT, AND (2) VOTING RESTRICTIONS AS SET FORTH
IN A VOTING AGREEMENT AMONG THE COMPANY AND THE ORIGINAL HOLDERS OF THESE SHARES, COPIES OF WHICH MAY BE OBTAINED AT THE PRINCIPAL
OFFICE OF THE COMPANY.

 

The
Investors consent to the Company making a notation on its records and giving instructions to any transfer agent of the Restricted
Securities in order to implement the restrictions on transfer established in this Section 2.8.

 

    -12-

     

    

 

(d)            The
first legend referring to federal and state securities laws identified in Section 2.8(c) stamped on a certificate
evidencing the Restricted Securities and the stock transfer instructions and record notations with respect to the Restricted Securities
shall be removed and the Company shall issue a certificate without such legend to the holder of Restricted Securities if (i) those
securities are registered under the Securities Act, or (ii) the holder provides the Company with an opinion of counsel reasonably
acceptable to the Company to the effect that a sale or transfer of those securities may be made without registration or qualification.

 

(e)            Each
Investor agrees not to make any sale, assignment, transfer, pledge or other disposition of any securities of the Company, or any
beneficial interest therein, to any person (other than the Company) that would own 20% or more of the Company’s outstanding
voting equity securities (calculated on the basis of voting power) after such transfer unless and until such proposed transferee
confirms to the reasonable satisfaction of the Company that neither the proposed transferee nor any of its directors, executive
officers, other officers that may serve as a director or officer of any company in which it invests, general partners or managing
members nor any person that would be deemed a beneficial owner of those securities (in accordance with Rule 506(d) of
the Securities Act) is subject to any Bad Actor Disqualification, except as set forth in Rule 506(d)(2)(ii) or (iii) or
(d)(3) under the Securities Act and disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the
Company.

 

2.9           Rule 144
Reporting. With a view to making available the benefits of certain rules and regulations of the Commission that may permit
the sale of the Restricted Securities to the public without registration, the Company agrees to use its commercially reasonable
efforts to:

 

(a)            Make
and keep adequate current public information with respect to the Company available in accordance with Rule 144 under the Securities
Act, at all times from and after ninety (90) days following the effective date of the first registration under the Securities Act
filed by the Company for an offering of its securities to the general public;

 

(b)            File
with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the
Exchange Act at any time after it has become subject to such reporting requirements; and

 

(c)            So
long as an Investor owns any Restricted Securities, furnish to the Investor forthwith upon written request a written statement
by the Company as to its compliance with the reporting requirements of Rule 144 (at any time from and after ninety (90) days
following the effective date of the first registration statement filed by the Company for an offering of its securities to the
general public), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements),
a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed as an Investor
may reasonably request in availing itself of any rule or regulation of the Commission allowing an Investor to sell any such
securities without registration.

 

    -13-

     

    

 

2.10        Market
Stand-Off Agreement. Each Investor shall not sell or otherwise transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any Common Stock
(or other securities) of the Company held by such Investor (other than those included in the registration) during the period
from the filing of the registration statement for the Company’s Initial Public Offering filed under the Securities Act
that includes securities to be sold on behalf of the Company to the public in an underwritten public offering under the
Securities Act through the end of the 180-day period following the effective date of the registration statement (or such
other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on
(i) the publication or other distribution of research
reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NYSE
Rule 472(f)(4), or any successor provisions or amendments thereto). The obligations described in this Section 2.10 shall
not apply to (x) a registration relating solely to employee benefit plans on Form S-l or Form S-8 or similar
forms that may be promulgated in the future, (y) a registration relating solely to a transaction on Form S-4 or
similar forms that may be promulgated in the future or (z) any permitted transfers under this Agreement, and such
obligations shall be applicable to the Investors only if (A) all officers and directors are subject to the same
restrictions and (B) the Company uses commercially reasonable efforts to obtain a similar agreement from all
shareholders individually owning more than 1% of the Company’s outstanding Common Stock (after giving effect to
conversion into Common Stock of all outstanding Preferred Stock). The Company may impose stop-transfer instructions and may
stamp each such certificate with the second legend set forth in Section 2.8(c) with respect to the shares of
Common Stock (or other securities) subject to the foregoing restriction until the end of such one hundred eighty (180) day
(or other) period. Each Investor agrees to execute a market standoff agreement with said underwriters in customary form
consistent with the provisions of this Section 2.10.

 

2.11        Delay
of Registration. No Investor shall have any right to take any action to restrain, enjoin, or otherwise delay any registration
as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

 

2.12        Transfer
or Assignment of Registration Rights. The rights to cause the Company to register securities granted to an Investor by
the Company under this Section 2 may be transferred or assigned by an Investor only to a transferee or assignee
who (i) is an Affiliate of such Investor or (ii) would hold at least 1% of the outstanding Registrable Securities
after such transfer or assignment; provided that (i) such transfer or assignment of Registrable Securities is
effected in accordance with the terms of Section 2.8, (ii) the Company is given written notice prior to said
transfer or assignment, stating the name and address of the transferee or assignee and identifying the securities with
respect to which such registration rights are intended to be transferred or assigned and (iii) the transferee or
assignee of such rights assumes in writing the obligations of such Investor under this Agreement.

 

2.13        Limitations
on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior written
consent of Investors holding a majority of the Registrable Securities (excluding any of such shares held by any Investors whose
rights to request registration or inclusion in any registration pursuant to this Section 2 have terminated in accordance
with Section 2.14), enter into any agreement with any holder or prospective holder of any securities of the Company
giving such holder or prospective holder any registration rights the terms of which are senior or pari passu to the registration
rights granted to the Investors hereunder.

 

2.14        Termination
of Registration Rights. The right of any Investor to request registration or inclusion in any registration pursuant to Sections
2.1, 2.2 or 2.3 shall terminate upon the earlier to occur of (i) the third anniversary of the Qualified
IPO and (ii) such time as Rule 144 or another similar exemption under the Securities Act is available for the sale of
all of such Investor’s shares without limitation during a three- month period without registration.

 

SECTION 3

 

COVENANTS

 

		3.1	Basic Financial Information and Inspection Rights.

 

(a)            Basic
Financial Information. The Company will furnish the following reports to each Qualified Investor that so requests:

 

    -14-

     

    

 

(i)            As
soon as practicable after the end of each fiscal year of the Company, and in any event within ninety (90) days after the end of
each fiscal year of the Company, an unaudited consolidated balance sheet of the Company and its subsidiaries, if any, as at the
end of such fiscal year, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries, if
any, for such year, in each case prepared in accordance with U.S. GAAP; and

 

(ii)            As
soon as practicable after the end of each quarterly accounting period in each fiscal year of the Company, and in any event within
forty-five (45) days after the end of the each quarterly accounting period in each fiscal year of the Company, an unaudited consolidated
balance sheet of the Company and its subsidiaries, if any, as of the end of each such quarterly period, and unaudited consolidated
statements of income and cash flows of the Company and its subsidiaries, if any, for such period, in each case prepared in accordance
with U.S. GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not
contain all notes thereto that may be required in accordance with GAAP).

 

(b)           Inspection
and Other Rights. The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and
inspect the Company’s properties, examine its books of account and records, and discuss the Company’s affairs,
finances, and accounts with its officers during normal business hours of the Company as may be reasonably requested by such
Major Investor; provided, that the Company shall not be obligated pursuant to this Section 3.1(b) to
provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential
information (unless, in the case of confidential information, covered by an enforceable confidentiality agreement, in form
acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the
Company and its counsel. The Company will furnish to each Major Investor that so requests: (i) at least thirty (30) days
prior to the end of each fiscal year, a comprehensive operating budget forecasting the Company’s revenues, expenses,
and cash position on a month-to-month basis for the upcoming fiscal year and (ii) promptly following the end of each
fiscal quarter, an up-to-date capitalization table of the Company as of the end of such fiscal quarter.

 

3.2          Confidentiality.
Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for any purpose (other
than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of
this Agreement or otherwise (including notice of the Company’s intention to file a registration statement or in connection
with a Change of Control), unless such confidential information (a) is known or becomes known to the public in general (other
than as a result of a breach of this Section 3.2 by such Investor), (b) is or has been independently developed
or conceived by the Investor without use of the Company’s confidential information, or (c) is or has been made known
or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to
the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys,
accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring
its investment in the Company; (ii) to any prospective purchaser of any shares of Preferred Stock from such Investor, if such
prospective purchaser agrees to be bound by the provisions of this Section 3.2; (iii) to any existing or prospective
Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided
that such Investor informs such Person that such information is confidential and directs such Person to maintain the confidentiality
of such information; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the
Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. Notwithstanding anything
to the contrary in this Agreement, the Company shall not be required to comply with any information rights set forth in Section 3.1
or inspection rights in Section 3.2 in respect of any Investor whom the Board (including the Preferred Director
or Series B Director) determines in good faith to be a Competitor.

 

    -15-

     

    

 

3.3           “Bad
Actor” Notice. Each party to this Agreement will promptly notify each other party to this Agreement in writing if it
or, to its knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any Bad Actor
Disqualification.

 

3.4           Board
Matters. The Company shall reimburse the nonemployee directors for all reasonable out-of-pocket travel expenses incurred (consistent
with the Company’s travel policy) in connection with attending any in person meetings of the Board. Unless otherwise determined
by the vote of a majority of the directors then in office, the Board shall meet at least quarterly in accordance with an agreed-upon
schedule.

 

3.5           Observation
Rights. The Company will offer to David Zaslav, for so long as Snickers Holdings LLC and its permitted transferees own
1,408,500 shares of Series Seed Preferred Stock (as presently constituted and subject to subsequent adjustments for
stock splits, stock dividends, reverse stock splits, and the like) (or an equivalent amount of Common Stock issued upon
conversion thereof), for any period during which David Zaslav is not a member of the Board, an invitation to David Zaslav to
attend all meetings of the Board and in connection therewith shall provide to David Zaslav copies of all notices, minutes,
consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such
directors; provided however, that the Company reserves the right to withhold any information and to exclude David
Zaslav from any meeting or portion thereof if (i) access to such information or attendance at such meeting could
adversely affect the attorney-client privilege between the Company and its counsel; (ii) access to such information or
attendance at such meeting could result in disclosure of trade secrets to David Zaslav;
(iii) access to such information or attendance at such
meeting could result in a conflict of interest between David Zaslav and the Company or its counsel; or (iv) David Zaslav
is a direct competitor of the Company, as determined in good faith by the Board. David Zaslav may participate in discussions
of matters brought before the Board, but shall in all other respects be a nonvoting observer.

 

3.6           Directors
and Officers Insurance. The Company has as of the date hereof or shall obtain within ninety (90) days of the date hereof, from
financially sound and reputable insurers directors and officers liability insurance in an amount and on terms and conditions satisfactory
to the Board, and will use commercially reasonable efforts to cause such insurance policies to be maintained.

 

3.7           Successor
Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other entity and
is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper
provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect
to indemnification of members of the Board as in effect immediately before such transaction, whether such obligations are contained
in the Company’s Bylaws, its Restated Certificate, or elsewhere, as the case may be.

 

3.8           Termination
of Covenants. The covenants set forth in this Section 3 (other than Section 3.7) shall terminate and
be of no further force and effect (i) immediately before the closing of the Initial Public Offering, (ii) when the Company
first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, (iv) upon
a Change of Control or (iv) upon a Liquidation Event, whichever event occurs first.

 

    -16-

     

    

 

SECTION 4

 

RIGHT OF FIRST REFUSAL

 

4.1           Right
of First Refusal to Investors. The Company hereby grants to each Major Investor, the right of first refusal to purchase
its pro rata share of New Securities (as defined in this Section 4.1(a)) which the Company may, from time
to time, propose to sell and issue after the date of this Agreement (“Preemptive Rights”). A Major
Investor’s pro rata share, for purposes of this right of first refusal, is equal to the ratio of (a) the
number of shares of Common Stock owned by such Major Investor immediately prior to the issuance of New Securities (assuming
full conversion of the shares of Preferred Stock and full conversion or exercise of all outstanding convertible securities,
rights, options and warrants held by said Major Investor) to (b) the total number of shares of Common Stock outstanding
immediately prior to the issuance of New Securities (assuming full conversion of all shares of Preferred Stock and full
conversion or exercise of all outstanding convertible securities, rights, options and warrants of the Company, and including
all shares reserved for issuance under the Company’s equity incentive plans). This right of first refusal shall be
subject to the following provisions:

 

(a)           “New
Securities” means any capital stock (including Common Stock and/or Preferred Stock) of the Company whether now or
hereafter authorized, and rights, convertible securities, options or warrants to purchase such capital stock, and securities of
any type whatsoever that are, or may become, exercisable or convertible into capital stock; provided, that the term “New
Securities” does not include the shares of Preferred Stock issued pursuant to the Purchase Agreement, the Conversion
Stock and issuances or deemed issuances of Exempted Securities (as defined in the Restated Certificate).

 

(b)            In
the event the Company proposes to undertake an issuance of New Securities, it shall give each Major Investor written notice of
its intention, describing the type of New Securities, and their price and the general terms upon which the Company proposes to
issue the same. Each Major Investor shall have ten (10) days after any such notice is mailed or delivered to agree to purchase
such Major Investor’s pro rata share of such New Securities upon the terms specified in the notice by giving written
notice to the Company, in substantially the form attached as Schedule 1, and stating therein the quantity of New Securities to
be purchased.

 

(c)            In
the event the Major Investors fail to exercise fully the right of first refusal within said ten (10) day period (the “Election
Period”), the Company shall have ninety (90) days thereafter to sell or enter into an agreement (pursuant to which
the sale of New Securities covered thereby shall be closed, if at all, within ninety (90) days from the date of said agreement)
to sell that portion of the New Securities with respect to which the Major Investors’ right of first refusal option set forth
in this Section 4.1 was not exercised, at a price and upon terms no more favorable to the purchasers thereof than specified
in the Company’s notice to Major Investors delivered pursuant to Section 4.1(a). In the event the Company has
not sold within such ninety (90) day period following the Election Period, or such ninety (90) day period following the date of
said agreement, the Company shall not thereafter issue or sell any New Securities, without first again offering such securities
to the Major Investors in the manner provided in this Section 4.1.

 

(d)            The
right of first refusal granted under this Agreement shall expire immediately before the closing of the Initial Public Offering.

 

(e)            An
Investor will not have a right of first refusal to purchase a pro rata share of New Securities in accordance with this Section 4
and will not be an Investor for purposes of the right of first refusal granted under this Section 4 if, and for
so long as, the Investor, any of its directors, executive officers, other officers that may serve as a director or officer of any
company in which it invests, general partners or managing members or any person that would be deemed a beneficial owner of the
securities of the Company held by the Investor (in accordance with Rule 506(d) of the Securities Act) is subject to any
Bad Actor Disqualification, except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities
Act.

 

    -17-

     

    

 

SECTION 5

 

MISCELLANEOUS

 

5.1
          Amendment. Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged
or terminated other than by a written instrument referencing this Agreement and signed by (i) the Company and (ii) the
Investors holding a majority of the Registrable Securities held by the Investors (excluding any of such shares that have been
sold to the public or pursuant to Rule 144); provided, however that investors purchasing shares of Series B
Preferred Stock in a Closing after the Initial Closing (each as defined in the Purchase Agreement) may become parties to this
Agreement, by executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this section or any
consent or approval of any other Investor; provided, further, that if any amendment, waiver, discharge or termination operates
in a manner that treats any Investor different from other Investors, the consent of such Investor shall also be required for such
amendment, waiver, discharge or termination. Any such amendment, waiver, discharge or termination effected in accordance with
this section shall be binding upon each Investor and each future holder of all such securities of Investor. Each Investor acknowledges
that by the operation of this section, the holders of a majority of Registrable Securities held by the Investors (excluding any
of such shares that have been sold to the public or pursuant to Rule 144) will have the right and power to diminish or eliminate
all rights of such Investor under this Agreement. For purposes of this Section 5.1, the requirement of a written instrument
may be satisfied in the form of an action by written consent of the Investors circulated by the Company and executed by the parties
specified.

 

5.2           Notices. All notices and other communications
required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent
by facsimile or electronic mail (if to an Investor) or otherwise delivered by hand, messenger or courier service addressed:

 

(a)            if
to an Investor, to the Investor’s address, facsimile number or electronic mail address as shown in the Exhibit A to
the Purchase Agreement; or

 

(b)            if
to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 499 East 34th
Street, New York, NY 10016, or at such other current address as the Company shall have furnished to the Investors, with a copy
(which shall not constitute notice) to Sacha Ross, Cooley LLP, 1114 Avenue of the Americas, 46th Floor, New York, NY 10036.

 

Each
such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if
delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service,
freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent
via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for
the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation
of facsimile transfer or, if sent via electronic mail, when directed to the relevant electronic mail address, if sent during normal
business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next
business day.

 

Subject
to the limitations set forth in Delaware General Corporation Law §232(e), each Investor consents to the delivery of any
notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s certificate of
incorporation or bylaws by (i) facsimile telecommunication to the facsimile number set forth on Exhibit A (or to
any other facsimile number for the Investor in the Company’s records), (ii) electronic mail to the electronic mail
address set forth on Exhibit A (or to any other electronic mail address for the Investor in the Company’s
records), (iii) posting on an electronic network together with separate notice to the Investor of such specific posting
or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the
Investor. This consent may be revoked by an Investor by written notice to the Company and may be deemed revoked in the
circumstances specified in Delaware General Corporation Law §232.

 

    -18-

     

    

 

5.3           Governing
Law. This Agreement shall be governed in all respects by the internal laws of the State of New York as applied to agreements
entered into among New York residents to be performed entirely within New York, without regard to principles of conflicts of law.

 

5.4           Successors
and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred,
delegated or sublicensed by any Investor without the prior written consent of the Company, other than to a permitted transferee
in connection with a permitted transfer under this Agreement. Any attempt by an Investor without such permission to so assign,
transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement shall be void. Subject to the
foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

5.5           Entire
Agreement. This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between the parties
with regard to the subjects hereof and supersedes in its entirety the Prior Agreement, which shall have no further force and effect.
This Agreement shall be deemed an amendment and restatement of the Prior Agreement, and any party thereto who does not execute
and deliver this Agreement will nevertheless be deemed a party hereunder and have all of the rights, benefits and obligations associated
therewith. No party hereto shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof
by any warranties, representations or covenants except as specifically set forth herein.

 

5.6           Delays
or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to
any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power
or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of
any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any
party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.

 

5.7           Severability.
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement,
and such court will replace such illegal, void or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable
provision. The balance of this Agreement shall be enforceable in accordance with its terms.

 

5.8           Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless
otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

    -19-

     

    

 

5.9           Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute
such counterparts, and all of which together shall constitute one instrument.

 

5.10        Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties
hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of
or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all purposes.
At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any
facsimile, telecopy or other reproduction hereof.

 

5.11        Jurisdiction;
Venue. With respect to any disputes arising out of or related to this Agreement, the parties consent to the exclusive jurisdiction
of, and venue in, the state courts in New York County, New York (or in the event of exclusive federal jurisdiction, the courts
of the Southern District of New York).

 

5.12        Further
Assurances. Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company,
partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may
be necessary to more fully effectuate this Agreement.

 

5.13        Termination
Upon Change of Control. Notwithstanding anything to the contrary herein, this Agreement (excluding any then-existing obligations)
shall terminate upon (a) the acquisition of the Company by another entity by means of any transaction or series of related
transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation
but excluding any sale of stock for capital raising purposes) other than a transaction or series of transactions in which the holders
of the voting securities of the Company outstanding immediately prior to such transaction continue to retain (either by such voting
securities remaining outstanding or by such voting securities being converted into voting securities of the surviving entity),
as a result of shares in the Company held by such holders prior to such transaction, at least fifty percent (50%) of the total
voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction
or series of transactions; or (b) a sale, lease or other conveyance of all substantially all of the assets of the Company
(a “Change of Control”).

 

5.14        Conflict.
In the event of any conflict between the terms of this Agreement and the Company’s certificate of incorporation or its
bylaws, the terms of the Company’s certificate of incorporation or its bylaws, as the case may be, will control.

 

5.15        Attorneys’
Fees. In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party in
such dispute shall be entitled to recover from the losing party such reasonable fees and expenses of attorneys and accountants,
which shall include, without limitation, all fees, costs and expenses of appeals.

 

5.16        Aggregation
of Stock. All securities held or acquired by affiliated entities (including affiliated venture capital funds) or persons shall
be aggregated together for purposes of determining the availability of any rights under this Agreement. For all purposes of this
Agreement, Andrew Farkas and i- Hatch Management LLC shall be deemed to be affiliated persons.

 

    -20-

     

    

 

5.17        Jury
Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS AGREEMENT.

 

5.18        Right
to Conduct Activities. The Company hereby agrees and acknowledges that each Investor (together with its affiliates) may make
investments or otherwise conduct activities which may be deemed competitive with the Company’s business (as currently conducted
or as currently proposed to be conducted). The Company hereby agrees that, to the extent permitted under applicable law, no Investor
shall be liable to the Company for any claim arising out of, or based upon, (i) the investment or other activity by any Investor
or any of its affiliates with respect to any entity competitive with the Company, or (ii) actions taken by any Investor or
any of its affiliates to assist any such competitive company, whether or not such action was taken as a member of the board of
directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company; provided,
however, that the foregoing shall not relieve any of the Investors from liability associated with the unauthorized disclosure
of the Company’s confidential information obtained pursuant to this Agreement or breach of any other agreement between Investor
and the Company.

 

(signature page follows)

 

    -21-

     

    

 

The parties are signing this Amended and Restated Investors'
Rights Agreement as of the date stated in the introductory clause.

 

	  	FLY BLADE, INC.
	 	a Delaware corporation
	 	 
	 	By: 	/s/ Rob Wiesenthal
	 	Name:	Rob Wiesenthal
	 	Title: 	Chief Executive Officer

 

(Signature page to the
Amended and Restated Investors’ Rights Agreement)

 

    

     

    

 

The parties are signing this Amended
and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	 
	 	COLPE BLADE INVESTOR, LLC
	 	 
	 	By: 	/s/
    Mark M. Hedstrom
	 	 	 
	 	Name. 	Mark
    M. Hedstrom
	 	 	 
	 	Title: 	Vice
    President

 

(Signature
page to the Amended and Restated Investors' Rights Agreement)

 

    

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	 
	 	LERER HIPPEAU VENTURES V, LP
	 	 
	 	By: 	Lerer Hippeau Ventures V
    GP, LLC, its General
	 	 
	 	 
	 	By: 	/s/ Eric
    Hippeau
	 	 	 
	 	Name: 	Eric
    Hippeau
	 	 	 
	 	Title: 	Managing
    Member

 

(Signature
page to the Amended and Restated Investors' Rights Agreement)

 

    

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	 
	 	LERER HIPPEAU
    VENTURES SELECT FUND, LP
	 	 
	 	By: 	Lerer Hippeau
    Ventures Select Fund LP, LLC, its General Partner
	 	 
	 	 
	 	By: 	/s/
    Eric Hippeau
	 	 	 
	 	Name: 	Eric
    Hippeau
	 	 	 
	 	Title: 	Managing
    Member

 

(Signature
page to the Amended and Restated Investors' Rights Agreement)

 

    

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 	 	INVESTOR
	 	 
	 	 	Lerer
    Investments II, LLC
	 	 	(Print
    investor name)
	 	 	 
	 	 	/s/
    Kenneth Lerer
	 	 	(Signature)
	 	 	 
	 	 	Kenneth
    Lerer
	 	 	(Print name of signatory,
    if signing for an entity)
	 	 	 
	 	 	Managing
    Member
	 	 	(Print title of signatory,
    if signing for an entity)

 

(Signature
page to the Amended and Restated Investors' Rights Agreement)

 

    

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		Andrew Bazos
	 	(Print investor name)

 

		/s/Andrew Bazos
	 	(Signature)

 

(Signature page to the Amended and
Restated Investors’ Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		Andrew Farkas
	 	(Print investor name)

 

		  /s/ Andrew Farkas
	 	(Signature)

 

(Signature page to the Amended and
Restated Investors’ Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		  Gerald J. Cardinale
	 	(Print investor name)

 

		  /s/ Gerald J. Cardinale
	 	(signature)

 

(Signature page to the Amended and
Restated Investors’ Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		I-HATCH MANAGEMENT LLC

 

		By:	/s/ Bradford Farkas

 

		Name:	 Bradford Farkas

 

		Title:	Managing
Member

 

(Signature page to the Amended and Restated Investors’
Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		 MATTHEW JACOBSON TRUST UAD

6/9/10

 

		By:	   /s/ Matthew Jacobson

 

		Name:	 Matthew Jacobson

 

		Title:	 Trustee

 

(Signature page to the Amended and Restated Investors’
Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		 PLYMOUTH TECHNOLOGY LLC
	 	 
	 	By: Plymouth Investment, LP, its Sole
Member

 

		By:	    /s/ Richard Mishaan

 

		Name:	  Richard Mishaan

 

		Title:	 Mng
director

 

(Signature page to the Amended and Restated Investors’
Rights Agreement)

 

     

     

    

 

The
parties are signing this Amended and Restated Investors'
Rights Agreement as of the
date stated in the introductory clause.

 

	 	INVESTOR

 

		RAINE VENTURE PARTNERS I LP
	 	 
	 	By: Raine Venture Associates I LP, its general 

                                                                         partner

	 	 
	 	By: Raine Management LLC, its general partner

 

		By:	  /s/ Alfred Chianese

 

		Name:	 Alfred Chianese

 

		Title:	  Vice President

 

(Signature page to the Amended and Restated Investors’
Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

		    Snickers Holdings LLC
	 	(Print investor name)

 

		  /s/ David Zaslav
	 	(Signature)

 

		David
                                         Zaslav
	 	(Print name of signatory, if signing for an entity)

 

		President
	 	(Print title of signatory, if signing for an entity)

 

(Signature
page to the Amended and Restated Investors’ Rights Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Investors' Rights Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR

 

	 	ROB WIESENTHAL

 

		  /s/
Rob Wiesenthal 
	 	(Signature)

 

(Signature
page to the Amended and Restated Investors’ Rights Agreement)

 

     

     

    

 

The parties
are signing this Amended and Restated Investors'
Rights Agreement as of the
date stated in
the introductory clause.

 

	 	INVESTOR

 

		AIRBUS HELICOPTERS S.A.S. 

 

		By:	     /s/ Clive Schley 

 

		Name:	Clive Schley

 

		Title:	SVP Strategy

 

(Signature page to the Amended and Restated Investors’
Rights Agreement)

 

     

     

    

 

The parties are signing this Amended and
Restated Investors' Rights Agreement as of the date stated in the introductoryclause.

 

	 	INVESTOR

 

		LIONTREE
PARTNERS LLC 

 

		By:	          /s/
Matthew Derdeyn

 

		Name:	       Matthew
Derdeyn

 

		Title:	          CHIEF FINANCIAL OFFICER

 

(Signature
page to the Amended and Restated Investors' Rights Agreement )

 

     

     

    

 

The
parties are signing this Amended and
Restated Investors' Rights Agreement as
of the date stated
in the introductory clause.

 

	 	INVESTOR

 

		JUST BLADE, LLC

 

		By:	      /s/ Mark Hedstrom

 

		Name:	
 Mark M. Hedstrom

 

		Title:	  Vice PresidentExhibit 10.6

 

FLY BLADE, INC.

 

AMENDED AND RESTATED
RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT

 

January 30,
2018

 

    

     

    

 

TABLE OF CONTENTS

 

	 	 	 	 	Page
	 	 	 	 	 
	SECTION 1 DEFINITIONS	 	1
	1.1	 	Certain Definitions	 	1
	SECTION 2 RESTRICTIONS ON TRANSFER	 	4
	2.1	 	General	 	4
	2.2	 	Notice
    of Proposed Transfer	 	4
	SECTION 3 RIGHT OF FIRST REFUSAL	 	4
	3.1	 	Exercise
    by the Company	 	4
	3.2	 	Initial
    Exercise by the Eligible Investors	 	5
	3.3	 	Subsequent
    Exercise by Eligible Investors	 	5
	3.4	 	Purchase Price	 	5
	3.5	 	Closing;
    Payment	 	6
	3.6	 	Exclusion
    from Right of First Refusal	 	6
	3.7	 	No
    Right of First Refusal for Bad Actors	 	6
	SECTION 4 RIGHT OF CO-SALE	 	6
	4.1	 	Exercise
    by the Eligible Investors	 	6
	4.2	 	Closing;
    Consummation of the Co-Sale	 	7
	4.3	 	Exclusion
    from Co-Sale Right	 	7
	4.4	 	Multiple
    Series, Class or Type of Stock	 	7
	4.5	 	Seller’s Right to Transfer	 	7
	SECTION 5 CONDITIONS TO VALID TRANSFER	 	7
	5.1	 	Generally	 	7
	5.2	 	Put
    Right	 	8
	5.3	 	No
    Transfers to Bad Actors	 	8
	SECTION 6 RESTRICTIVE LEGEND AND STOP TRANSFER ORDERS	 	9
	6.1	 	Legend	 	9
	6.2	 	Stop
    Transfer Instructions	 	9
	SECTION 7 TERMINATION	 	9
	7.1	 	Termination	 	9
	SECTION 8 MISCELLANEOUS	 	9
	8.1	 	Notices	 	9
	8.2	 	Successors
    and Assigns	 	10
	8.3	 	Severability	 	11
	8.4	 	Amendment	 	11
	8.5	 	Additional
    Parties	 	11

 

    -i-

     

    

 

	8.6	 	Continuity
    of Other Restrictions	 	12
	8.7	 	Governing
    Law	 	12
	8.8	 	Counterparts	 	12
	8.9	 	Further
    Assurances	 	12
	8.10	 	Conflict	 	12
	8.11	 	Attorney’s Fees	 	12
	8.12	 	Titles
    and Subtitles	 	12
	8.13	 	Entire
    Agreement	 	12
	8.14	 	Delays
    or Omissions	 	13
	8.15	 	Telecopy
    Execution and Delivery	 	13
	8.16	 	Jurisdiction;
    Venue	 	13
	8.17	 	Aggregation	 	13
	8.18	 	Jury
    Trial	 	13

 

    -ii-

     

    

 

FLY BLADE, INC.

AMENDED
AND RESTATED 

RIGHT OF FIRST REFUSAL
AND CO-SALE AGREEMENT

 

This
Amended and Restated Right of First Refusal and Co-Sale Agreement (this “Agreement”) is dated as of January 30,
2018, and is between Fly Blade, Inc., a Delaware corporation (the “Company”), the individuals and
entities listed on Exhibit A (each, an “Investor,” and collectively, the “Investors”),
and the individuals listed on Exhibit B (each, a “Key Holder,” and collectively, the “Key
Holders”).

 

RECITALS

 

WHEREAS,
the Company, the Key Holders and certain of the Investors (the “Prior Investors”) previously entered
into an Amended and Restated Right of First Refusal and Co-Sale Agreement, dated May 3, 2016 (the “Prior Agreement”).

 

WHEREAS,
the Company and certain of the Investors are parties to the Series B Preferred Stock Purchase Agreement (as amended from time
to time, the “Purchase Agreement”) of even date herewith, between the Company and such Investors (the
 “Financing”), and it is a condition to the closing of the Financing that the Company, the Key Holders
and the Investors execute and deliver this Agreement.

 

WHEREAS,
the Company, the Key Holders and the Prior Investors intend that the Prior Agreement shall be superseded and replaced in its entirety
by this Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, the Company, the Key Holders and the Investors holding a sufficient number of shares of the Company’s capital
stock hereby agree to amend and restate the Prior Agreement in its entirety as set forth herein, and the parties hereto hereby
agree as follows:

 

SECTION 1

 

DEFINITIONS

 

1.1           Certain
Definitions. For purposes of this Agreement, the following terms have the following meanings:

 

(a)           “Affiliate”
means, with respect to any specified person or entity, any other person or entity who directly or indirectly, controls, is controlled
by or is under common control with such person or entity, including, without limitation, any general partner, managing member,
officer or director of such person or entity, or any venture capital fund now or hereafter existing which is controlled by one
or more general partners or managing members of, or shares the same management company with, such person or entity.

 

(b)           “Bad
Actor Disqualification” means any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through
(viii) under the Securities Act.

 

		(c)	“Common Stock” means the common stock of the Company.

 

(d)           “Change
of Control” means the acquisition of the Company by another entity by means of any transaction or series of
related transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization,
merger or consolidation but excluding any sale of stock for capital raising purposes) other than a transaction or series of
transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction
continue to retain (either by such voting securities remaining outstanding or by such voting securities being converted into
voting securities of the surviving entity), as a result of shares in the Company held by such holders prior to such
transaction, at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or
such surviving entity outstanding immediately after such transaction or series of transactions.

 

    -1-

     

    

 

(e)           “Convertible
Securities” means all then outstanding options, warrants, rights, convertible notes, preferred stock or other securities
of the Company directly or indirectly convertible into or exercisable for shares of Common Stock.

 

(f)            “Co-Sale
Eligible Investor” means each Eligible Investor who has not exercised its right in Section 3.2.

 

(g)           “Days”
means calendar days; provided that if any day on which a period specified in this Agreement would otherwise terminate falls
on a weekend or a federal holiday, the term “day” shall mean the next business day.

 

(h)           “Eligible
Investor” means any Investor (together with its Affiliates) who holds shares of Preferred Stock with an aggregate
liquidation preference of $499,995.

 

(i)            “Preferred
Stock” means, collectively, the Series Seed Preferred Stock, the Series A Preferred Stock and the Series B
Preferred Stock.

 

(j)            “Rights
of Co-Sale” means the rights of co-sale provided to the Co-Sale Eligible Investors in Section 4.

 

(k)           “Rights
of First Refusal” means the rights of first refusal provided to the Company and the Eligible Investors in Section 3.

 

		(l)	“Securities Act” means the Securities Act of 1933, as amended.

 

(m)          “Seller”
means any (i) Investor that is not an Eligible Investor or (ii) Key Holder proposing to Transfer Seller Shares.

 

(n)           “Seller
Shares” means all shares of capital stock of the Company owned as of the date hereof or hereafter acquired by a Seller,
as adjusted for any stock splits, stock dividends, combinations, subdivisions, recapitalizations and the like.

 

(o)           “Series A
Preferred Stock” means the Company’s Series A Preferred Stock, par value $0.00001 per share.

 

(p)           “Series B
Preferred Stock” means the Company’s Series B Preferred Stock, par value $0.00001 per share.

 

(q)           “Series Seed
Preferred Stock” means, the Company’s Series Seed Preferred Stock, par value $0.00001 per share

 

(r)            “Transfer,”
 “Transferring,” “Transferred,” or words of similar import, mean and
include any sale, assignment, encumbrance, hypothecation, pledge, conveyance in trust, gift, transfer by bequest, devise or
descent, or other transfer or disposition of any kind, including but not limited to transfers to receivers, levying
creditors, trustees or receivers in bankruptcy proceedings or general assignees for the benefit of creditors, whether
voluntary or by operation of law, directly or indirectly, except:

 

    -2-

     

    

 

(i)            any
bona fide pledge made to a financial institution pursuant to a bona fide loan transaction that creates a mere security
interest; provided, that the pledgee executes a counterpart copy of this Agreement and becomes bound thereby as a Seller
in the event that and to the extent that such pledgee ever acquires ownership of such pledged shares;

 

(ii)           any
transfers of Seller Shares by a Seller to Seller’s spouse, ex-spouse, domestic partner, lineal descendant or antecedent,
brother or sister, the adopted child or adopted grandchild, or the spouse or domestic partner of any child, adopted child, grandchild
or adopted grandchild of Seller, or to a trust or trusts for exclusive benefit of Seller or those members of Seller’s family
specified in this Section 1.1(r)(ii) or transfers of Seller Shares by Seller by devise or descent; provided,
that, in all cases, the transferee or other recipient executes a counterpart copy of this Agreement and becomes bound thereby
as was Seller;

 

(iii)          any
bona fide gift effected for tax planning purposes; provided, that the pledgee, transferee, donee or other recipient
executes a counterpart copy of this Agreement and becomes bound thereby as was Seller;

 

(iv)          any
transfer of Seller Shares originally purchased by (A) a Key Holder for cash or cash equivalents at a bona fide valuation or
(B) an Investor; provided, that any such transfer may not exceed an aggregate maximum amount of 10% of Seller Shares
(calculated as of the date of this Agreement and as may be adjusted from time to time for stock splits, stock dividends, combinations,
subdivisions, recapitalizations and the like) purchased for cash or cash equivalents held by such Key Holder or Investor;

 

(v)           any
involuntary transfer of Seller Shares by operation of law (e.g., bankruptcy, divorce or death);

 

(vi)          any
transfer by Seller to an Affiliate of such Seller for no consideration; provided that, in all cases, the transferee or other
recipient executes a counterpart copy of this Agreement and becomes bound thereby as was Seller; and

 

(vii)         any
transfer to the Company or an Eligible Investor pursuant to the terms of this Agreement; and

 

(viii)        any
repurchase of Seller Shares by the Company at a price no greater than that originally paid by such Key Holder for such Seller
Shares pursuant to agreements approved by the Board of Directors under which the Company has the option to repurchase such
Seller Shares upon the occurrence of a termination of employment; provided, that any pledgee, transferee or donee of a
pledge, transfer or gift made pursuant to subsections (ii), (iii) or (v) above shall remain subject to the Rights
of First Refusal set forth in Section 3 and the Right of Co- Sale set forth in Section 4.

 

If
a Seller plans to make any of the above excepted transfers, then, prior to transferring its Seller Shares, the Seller shall
deliver to the Company a written notice stating: (i) Seller’s bona fide intention to make an excepted
transfer of its Seller Shares; (ii) the name, address and phone number of each proposed transferee; (iii) the
aggregate number of Seller Shares to be transferred to each proposed transferee; (iv) the section in this agreement upon
which Seller is relying in making an excepted transfer; and (v) whether any proposed transferee (if such proposed
transferee would own 20% or more of the Company’s outstanding voting equity securities (calculated on the basis
of voting power) after such transfer) or any of its directors, executive officers, other officers that may serve as a
director or officer of any company in which it invests, general partners or managing members or any person that would be
deemed a beneficial owner (if such beneficial owner would be deemed to own 20% or more of the Company’s outstanding
voting equity securities (calculated on the basis of voting power) after such transfer) of those securities (in accordance
with Rule 506(d) of the Securities Act) is subject to any Bad Actor Disqualification (except for Bad Actor
Disqualifications covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and
disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company).

 

    -3-

     

    

 

SECTION 2

 

RESTRICTIONS ON TRANSFER

 

2.1            General.
Before a Seller may Transfer any Seller Shares, Seller must comply with the provisions of Section 2.2, Section 3
and Section 4. Each Key Holder and Investor represents and warrants that it is the sole legal and beneficial owner
of its Seller Shares and, subject to any restrictions imposed under the Company’s certificate of incorporation or bylaws,
or under any restricted stock purchase agreement with the Company, that no other person or entity has any interest (other than
a community property interest) in such shares.

 

2.2            Notice
of Proposed Transfer. Prior to Seller Transferring any of its Seller Shares, Seller shall deliver to the Company and the
Eligible Investors a written notice (the “Transfer Notice”), not later than thirty (30) days prior
to the consummation of such proposed Transfer, in substantially the form attached hereto as Exhibit C, stating:
(i) Seller’s bona fide intention to Transfer such Seller Shares; (ii) the name, address and phone
number of each proposed purchaser or other transferee (each, a “Proposed Transferee”);
(iii) the aggregate number of Seller Shares proposed to be Transferred to each Proposed Transferee (the
 “Offered Shares”); (iv) the bona fide cash price or, in reasonable detail, other
consideration for which Seller proposes to Transfer the Offered Shares (the “Offered Price”);
(v) each Eligible Investor’s right to exercise either its Right of First Refusal or its Right of Co-Sale (but not
both rights) with respect to the Offered Shares; and (vi) whether any Proposed Transferee who would own 20% or more of
the Company’s outstanding voting equity securities (calculated on the basis of voting power) after such transfer or any
of such Proposed Transferee’s directors, executive officers, other officers that may serve as a director or officer of
any company in which it invests, general partners or managing members or any person that would be deemed a beneficial owner
(if such beneficial owner would be deemed to own 20% or more of the Company’s outstanding voting equity securities
(calculated on the basis of voting power) after such transfer) of the Offered Shares (in accordance with
Rule 506(d) of the Securities Act) is subject to any Bad Actor Disqualification (except for Bad Actor
Disqualifications covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and
disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company).

 

SECTION 3

 

RIGHT OF FIRST REFUSAL

 

		3.1	Exercise by the Company.

 

(a)            For
a period of twenty (20) days (the “Initial Exercise Period”) after the last date on which the Transfer
Notice is, pursuant to Section 8.1, deemed to have been delivered to the Company and all Eligible Investors, the Company
shall have the right to purchase all or any part of the Offered Shares on the terms and conditions set forth in this Section 3.
In order to exercise its right hereunder, the Company must deliver written notice to Seller within the Initial Exercise Period.

 

    -4-

     

    

 

(b)            Upon
the earlier to occur of (i) the expiration of the Initial Exercise Period or (ii) the time when Seller has received written
confirmation from the Company regarding its exercise of its Right of First Refusal, the Company shall be deemed to have made its
election with respect to the Offered Shares, and the shares for which the Eligible Investors may exercise their Rights of First
Refusal (as described below) shall be correspondingly reduced, if appropriate.

 

		3.2	Initial Exercise by the Eligible Investors.

 

(a)            Subject
to the limitations of this Section 3.2, during the Initial Exercise Period, the Eligible Investors shall have the right
to purchase, in the aggregate, all or any part of the Offered Shares not purchased by the Company pursuant to Section 3.1
(the “Remaining Shares”) on the terms and conditions set forth in this Section 3. In
order to exercise its rights hereunder, such Eligible Investor must provide written notice delivered to Seller within the Initial
Exercise Period.

 

(b)            To
the extent the aggregate number of shares that the Eligible Investors desire to purchase (as evidenced in the written notices delivered
to Seller) exceeds the Remaining Shares, each Eligible Investor so exercising will be entitled to purchase its pro rata share of
the Remaining Shares, which shall be equal to that number of the Remaining Shares equal to the product obtained by multiplying
(x) the number of Remaining Shares by (y) a fraction, (i) the numerator of which shall be the number of shares of
Common Stock (assuming conversion of all Preferred Stock and other Convertible Securities into Common Stock) held by such Eligible
Investor on the date of the Transfer Notice and (ii) the denominator of which shall be the number of shares of Common Stock
(assuming conversion of all Preferred Stock and other Convertible Securities into Common Stock) held on the date of the Transfer
Notice by all Eligible Investors exercising their Rights of First Refusal (“Pro Rata ROFR Share”).

 

(c)            Within
five (5) days after the expiration of the Initial Exercise Period, Seller will give written notice to the Company and each
Eligible Investor specifying the number of Offered Shares to be purchased by the Company and each Eligible Investor exercising
its Right of First Refusal (the “ROFR Confirmation Notice”). The ROFR Confirmation Notice shall also
specify the number of Offered Shares not purchased by the Company or the Eligible Investors, if any, pursuant to Sections 3.1
and 3.2 (“Unsubscribed Shares”) and shall list each Participating Investor’s (as defined
in Section 3.3) Subsequent Pro Rata Share (as described in Section 3.3) of any such Unsubscribed Shares.

 

3.3            Subsequent
Exercise by Eligible Investors. To the extent that there remain any Unsubscribed Shares, each Eligible Investor electing to
exercise its right to purchase at least its full Pro Rata ROFR Share of the Remaining Shares under Section 3.2 (a “Participating
Investor”) shall have a right to purchase all or any part of the Unsubscribed Shares; however, to the extent
the aggregate number of shares that the Participating Investors desire to purchase (as evidenced in written notices delivered to
the Seller) exceeds the remaining Unsubscribed Shares, each Participating Investor so exercising (an “Electing Participating
Investor”) will be entitled to purchase that number of the Unsubscribed Shares equal to the product obtained by multiplying
(x) the number of Unsubscribed Shares by (y) a fraction, (i) the numerator of which shall be the number of shares
of Common Stock (assuming conversion of all Preferred Stock and Convertible Securities into Common Stock) held on the date of the
Transfer Notice by such Electing Participating Investor and (ii) the denominator of which shall be the number of shares of
Common Stock (assuming conversion of all Preferred Stock and Convertible Securities into Common Stock) held on the date of the
Transfer Notice by all Participating Investors (“Subsequent Pro Rata Share”). In order to exercise its
rights hereunder, such Electing Participating Investor must provide written notice to Seller with a copy to the Company and each
Eligible Investor within seven (7) days after the expiration of the Initial Exercise Period.

 

3.4            Purchase
Price. The purchase price for the Offered Shares to be purchased by the Company or by an Eligible Investor exercising its
Right of First Refusal under this Agreement will be the Offered Price, and will be payable as set forth in Section 3.5.
If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration will be
determined by the Board of Directors of the Company in good faith, which determination will be binding upon the Company, each
Eligible Investor and Seller, absent fraud or error.

 

    -5-

     

    

 

3.5            Closing;
Payment. Subject to compliance with applicable state and federal securities laws, the Company and the Eligible Investors exercising
their Rights of First Refusal shall effect the purchase of all or any portion of the Offered Shares, including the payment of the
purchase price, within ten (10) days after the later of (i) delivery of the ROFR Confirmation Notice and, (ii) delivery
of the Co-Sale Confirmation Notice (as defined in Section 4.1(c)) (the “Right of First Refusal Closing”).
Payment of the purchase price will be made, at the option of the party exercising its Right of First Refusal, (i) in cash
(by check), (ii) by wire transfer, (iii) by cancellation of all or a portion of any outstanding indebtedness of Seller
to the Company or the Eligible Investor, as the case may be, or (iv) by any combination of the foregoing. At such Right of
First Refusal Closing, Seller shall deliver to each of the Company and the Eligible Investors exercising their Rights of First
Refusal, one or more certificates, properly endorsed for transfer, representing such Offered Shares so purchased.

 

3.6            Exclusion
from Right of First Refusal. This Right of First Refusal shall not apply with respect to shares sold and to be sold by Eligible
Investors pursuant to the Right of Co-Sale (set forth in Section 4).

 

3.7            No
Right of First Refusal for Bad Actors. No Investor shall be an Eligible Investor for purposes of the Rights of First Refusal
if the Investor or any of its directors, executive officers, other officers that may serve as a director or officer of any company
in which it invests, general partners or managing members or any person that is a beneficial owner of the securities of the Company
held by the Investor (in accordance with Rule 506(d) of the Securities Act) is subject to any Bad Actor Disqualification,
except for Bad Actor Disqualifications covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities
Act and disclosed in writing in reasonable detail to the Company.

 

SECTION 4

 

RIGHT OF CO-SALE

 

		4.1	Exercise by the Eligible Investors.

 

(a)            Subject
to the limitations of this Section 4, to the extent the Company and the Eligible Investors do not exercise their respective
Rights of First Refusal with respect to all or any part of the Offered Shares or the Remaining Shares, as applicable, pursuant
to Section 3, then, each Co-Sale Eligible Investor shall have the right to participate in such sale of the Offered
Shares which are not being purchased by the Company or the Eligible Investors pursuant to their respective Rights of First Refusal
(“Residual Shares”), on the same terms and conditions as specified in the Transfer Notice, to the extent
described in Section 4.1(b). To exercise its rights hereunder, each Co-Sale Eligible Investor (a “Selling
Investor”) must have provided a written notice to Seller within the Initial Exercise Period indicating the number
of shares it holds that it wishes to sell pursuant to this Section 4.1.

 

(b)            Each
Selling Investor will be entitled to sell up to its pro rata share of the Residual Shares, which shall be equal to the
product obtained by multiplying (x) the number of Residual Shares by (y) a fraction, (i) the numerator of
which shall be the number of shares of Common Stock (assuming conversion of all Preferred Stock and Convertible Securities
into Common Stock) held on the date of the Transfer Notice by such Selling Investor and (ii) the denominator of which
shall be the number of shares of Common Stock (assuming conversion of all Preferred Stock and Convertible Securities into
Common Stock) held on the date of the Transfer Notice by Seller and the Selling Investors.

 

    -6-

     

    

 

(c)            Within ten (10) days after the expiration of the Initial Exercise Period, Seller will give written notice to the Company and
each Selling Investor specifying the number of Residual Shares to be sold by each Selling Investor exercising its Right of Co-Sale
(the “Co-Sale Confirmation Notice”).

 

4.2            Closing;
Consummation of the Co-Sale. Subject to compliance with applicable state and federal securities laws, the sale of the Residual
Shares by the Selling Investors shall occur within ten (10) days after delivery of the Co-Sale Confirmation Notice (the “Co-Sale
Closing”). If a Selling Investor exercised the Right of Co-Sale in accordance with this Section 4, then
such Selling Investor shall deliver to Seller at or before the Co-Sale Closing, one or more certificates, properly endorsed for
Transfer, representing the number of Residual Shares to which the Selling Investor is entitled to sell pursuant to this Section 4.
At the Co-Sale Closing, Seller shall cause such certificates or other instruments to be Transferred and delivered to the transferee
pursuant to the terms and conditions specified in the Transfer Notice, and Seller will remit, or will cause to be remitted, to
each Selling Investor, at the Co-Sale Closing, that portion of the proceeds of the Transfer to which each Selling Investor is entitled
by reason of each Selling Investor’s participation in such Transfer pursuant to the Right of Co-Sale.

 

4.3            Exclusion
from Co-Sale Right. This Right of Co-Sale shall not apply with respect to (i) Offered Shares sold or to be sold to Eligible
Investors or the Company pursuant to the Right of First Refusal or (ii) Preferred Stock (or shares issued or issuable upon
conversion of Preferred Stock).

 

4.4            Multiple
Series, Class or Type of Stock. If the Offered Shares consist of more than one series, class or type of security, Seller
has the right to Transfer hereunder each such series, class or type; provided that if, as to the Right of Co-Sale, a Selling
Investor does not hold any of such series, class or type and the Proposed Transferee is not willing, at the Co-Sale Closing, to
purchase some other series, class or type of security from such Selling Investor, or is unwilling to purchase any security from
such Selling Investor at the Co-Sale Closing, then such Selling Investor will have the put right (the “Put Right”)
set forth in Section 5.2.

 

4.5            Seller’s
Right to Transfer. If any of the Offered Shares remain available after the exercise of all Rights of First Refusal and all
Rights of Co-Sale, then the Seller shall be free to Transfer, subject to Section 5, any such remaining shares to the
Proposed Transferee at the Offered Price or a higher price in accordance with the terms set forth in the Transfer Notice; provided,
however, that if the Offered Shares are not so Transferred during the seventy-two (72) day period following the deemed delivery
of the Transfer Notice, then Seller may not Transfer any of such remaining Offered Shares without complying again in full with
the provisions of this Agreement.

 

SECTION 5

 

CONDITIONS
TO VALID TRANSFER

 

5.1            Generally. Any
attempt by any Seller to transfer any Seller Shares in violation of any provision of this Agreement will be void. No
securities shall be transferred by a Seller unless (i) such transfer is made in compliance with all of the terms of this
Agreement and all applicable federal and state securities laws and (ii) prior to such transfer, the transferee or
transferees sign a counterpart to this Agreement pursuant to which it or they agree to be bound by the terms of this
Agreement. The Company will not be required to (i) transfer on its books any shares that have been transferred in
violation of any provisions of this Agreement or (ii) treat as owner of such shares, or accord the right to vote or pay
dividends to any purchaser, donee or other transferee to whom such shares may have been so transferred.

 

    -7-

     

    

 

5.2            Put
Right. If a Seller Transfers any Seller Shares in contravention of the Right of Co-Sale under this Agreement (a “Prohibited
Transfer”), or if the Proposed Transferee of Offered Shares desires to purchase a class, series or type of stock
offered by Seller but not held by a Selling Investor, or the Proposed Transferee is unwilling to purchase any securities from a
Selling Investor, such Selling Investor may, by delivery of written notice to such Seller (a “Put Notice”)
within ten (10) days after the later of (i) the Co-Sale Closing and (ii) the date on which such Selling Investor
becomes aware of the Prohibited Transfer or the terms thereof, require such Seller to purchase from such Selling Investor that
number of shares of Preferred Stock (on an as-converted basis) or Common Stock (subject to Section 5.2(b)) that is
equal to the number of Residual Shares such Selling Investor would have been entitled to Transfer to the purchaser (the “Put
Shares”). Such sale shall be made on the following terms and conditions:

 

(a)            The
price per share at which the Put Shares are to be sold to Seller shall be equal to the price per share that the Selling Investor
would have received at the Co-Sale Closing of such Prohibited Transfer if such Selling Investor had sold such Put Shares at the
Co-Sale Closing. Such purchase price of the Put Shares shall be paid in cash or such other consideration as Seller received in
the Prohibited Transfer or at the Co-Sale Closing. Seller shall also reimburse the Selling Investor for any and all fees and expenses,
including, but not limited to, legal fees and expenses, incurred pursuant to the exercise or attempted exercise of such Selling
Investor’s Rights of Co-Sale pursuant to Section 4 or in the exercise of its rights under this Section 5
with respect to the Put Shares.

 

(b)            The
Put Shares of stock to be sold to Seller shall be of the same class or type as Transferred in the Prohibited Transfer or at the
Co-Sale Closing if such Selling Investor then owns securities of such class or type. If such Selling Investor does not own any
of such class or type, the Put Shares shall be shares of Common Stock (or Preferred Stock convertible into Common Stock at the
option of the holder thereof).

 

(c)            The
closing of such sale to Seller will occur within ten (10) days after the date of such Selling Investor’s Put Notice
to such Seller. At such closing, the Selling Investor shall deliver to Seller the certificate or certificates representing the
Put Shares to be sold, each certificate to be properly endorsed for transfer, and immediately upon receipt thereof, such Seller
shall pay the aggregate purchase price therefor, and the amount of reimbursable fees and expenses, as specified in Section 5.2(a).

 

5.3            No
Transfers to Bad Actors. Each Key Holder and Investor agrees not to make any sale, assignment, encumbrance, hypothecation,
pledge, conveyance in trust, gift, transfer by bequest, devise or descent, or other transfer or disposition of any kind of any
securities of the Company, or any beneficial interest therein, to any person (other than the Company) who would own 20% or more
of the Company’s outstanding voting equity securities (calculated on the basis of voting power) after such transfer unless
and until such proposed transferee confirms to the reasonable satisfaction of the Company that neither the proposed transferee
nor any of its directors, executive officers, other officers that may serve as a director or officer of any company in which it
invests, general partners or managing members nor any person that would be deemed a beneficial owner (if such beneficial owner
would be deemed own 20% or more of the Company’s outstanding voting equity securities (calculated on the basis of voting
power) after such transfer) of those securities (in accordance with Rule 506(d) of the Securities Act) is subject to
any Bad Actor Disqualification, except for Bad Actor Disqualifications covered by Rule 506(d)(2)(ii) or (iii) or
(d)(3) under the Securities Act and disclosed, reasonably in advance of the transfer or disposition, in writing in reasonable
detail to the Company.

 

    -8-

     

    

 

SECTION 6

 

RESTRICTIVE LEGEND AND
STOP TRANSFER ORDERS

 

6.1         Legend.
Each Key Holder and Investor understands and agrees that the Company will cause the legend set forth below, or a legend substantially
equivalent thereto, to be placed upon any certificate(s) or other documents or instruments evidencing ownership of Seller
Shares by such Key Holder or Investor:

 

THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE SOLD, DISPOSED OF OR OTHERWISE TRANSFERRED IN COMPLIANCE WITH CERTAIN RIGHTS
OF FIRST REFUSAL AND RIGHTS OF CO-SALE AS SET FORTH IN A AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT ENTERED
INTO BY THE HOLDER OF THESE SHARES, THE COMPANY AND CERTAIN STOCKHOLDERS OF THE COMPANY. A COPY OF SUCH AGREEMENT IS ON FILE AT
THE PRINCIPAL OFFICE OF THE COMPANY. SUCH RIGHTS OF FIRST REFUSAL AND RIGHTS OF CO-SALE ARE BINDING ON TRANSFEREES OF THESE SHARES.

 

6.2         Stop
Transfer Instructions. In order to ensure compliance with the restrictions referred to herein, each Key Holder and Investor
agrees that the Company may issue appropriate “stop transfer” certificates or instructions in the event of a transfer
in violation of any provision of this Agreement and that it may make appropriate notations to the same effect in its records.

 

SECTION 7

 

TERMINATION

 

7.1         Termination.
The Eligible Investors’ Rights of First Refusal and Rights of Co-Sale shall terminate upon the earliest to occur of
(i) the closing of an Initial Public Offering (as defined below), (ii) the date on which this Agreement is terminated
by a writing executed by holders of at least a majority of the shares of Preferred Stock then held by the Investors (on an as
converted to common basis), (iii) the dissolution or winding-up of the Company, or (iv) immediately prior to the effective
date of a Change of Control. The Company’s Right of First Refusal will terminate upon the earliest to occur of (x) a
written election of the Company pursuant to an action by the Board of Directors, or (y) the occurrence of any of (i), (ii),
(iii) or (iv) in the preceding sentence. An “Initial Public Offering” means the Company’s
first bona fide, firm commitment underwritten public offering pursuant to an effective registration statement filed under
the Securities Act of 1933, as amended, covering the offer and sale of the Company’s Common Stock.

 

SECTION 8

 

MISCELLANEOUS

 

8.1         Notices.
All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered
or certified mail, postage prepaid, sent by facsimile or electronic mail (if to an Investor, a Key Holder or any other holder
of Company securities subject to this Agreement) or otherwise delivered by hand, messenger or courier service addressed:

 

(a)           if
to an Investor, to the Investor’s address, facsimile number or electronic mail address as shown in the exhibits to this Agreement
or in the Company’s records, as may be updated in accordance with the provisions hereof;

 

    -9- 

     

    

 

(b)           if
to a Key Holder, to that person’s address, facsimile number or electronic mail address as shown in the exhibits to this Agreement
or in the Company’s records, as may be updated in accordance with the provisions hereof;

 

(c)           if
to any other holder of Company securities subject to this Agreement, to such address, facsimile number or electronic mail address
as shown in the exhibits to this Agreement or in the Company’s records, or, until any such holder so furnishes an address,
facsimile number or electronic mail address to the Company, then to the address, facsimile number or electronic mail address of
the last holder of such securities for which the Company has contact information in its records; or

 

(d)          if
to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 499 East 34th
Street, New York, NY 10016, or at such other current address as the Company shall have furnished to the Investors, Key Holders
or other such holders, with a copy (which shall not constitute notice) to Sacha Ross, Cooley LLP 1114 Avenue of the Americas, 46th
Floor, New York, NY 10036.

 

Each
such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if
delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service,
freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent
via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for
the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation
of facsimile transfer or, if sent via electronic mail, when directed to the relevant electronic mail address, if sent during normal
business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next
business day. In the event of any conflict between the Company’s books and records and this Agreement or any notice delivered
hereunder, the Company’s books and records will control absent fraud or error.

 

Subject
to the limitations set forth in Delaware General Corporation Law §232(e), each Investor, Key Holder or other security
holder consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law
or the Company’s certificate of incorporation or bylaws by (i) facsimile telecommunication to the facsimile
number set forth in the exhibits to this Agreement (or to any other facsimile number for the Investor, Key Holder or other
security holder in the Company’s records), (ii) electronic mail to the electronic mail address set forth in the
exhibits to this Agreement (or to any other electronic mail address for the Investor, Key Holder or other security holder in
the Company’s records), (iii) posting on an electronic network together with separate notice to the Investor, Key
Holder or other security holder of such specific posting or (iv) any other form of electronic transmission (as defined
in the Delaware General Corporation Law) directed to the Investor, Key Holder or other security holder. This consent may be
revoked by an Investor, Key Holder or other security holder by written notice to the Company and may be deemed revoked in the
circumstances specified in Delaware General Corporation Law §232.

 

8.2          Successors
and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred,
delegated or sublicensed by any Investor without the prior written consent of the Company. Any attempt by an Investor without
such permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement
shall be void. Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure
to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

    -10- 

     

    

 

8.3          Severability.
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement,
and such court will replace such illegal, void or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable
provision. The balance of this Agreement shall be enforceable in accordance with its terms.

 

8.4          Amendment.
Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated
other than by a written instrument referencing this Agreement and signed by (i) the Company, (ii) Key Holders holding
a majority of the Seller Shares (on an as- converted-to-common-stock basis) held by all Key Holders and (iii) Investors holding
a majority of the Common Stock issued or issuable upon conversion of the Preferred Stock held by the Investors (excluding any
of such shares that have been sold to the public or pursuant to Rule 144); provided, however, that:

 

(a)           Investors
purchasing Shares after the Closing (as such term is defined in the Purchase Agreement) may become parties to this Agreement by
executing a counterpart of this Agreement, without any amendment of this Agreement pursuant to this paragraph or any consent or
approval of any other Investor or Key Holder;

 

(b)           persons
or entities who acquire shares of Common Stock of the Company may become parties to this Agreement as Key Holders by executing
a counterpart of this Agreement, without any amendment of this Agreement, pursuant to this Section 8.4 or any consent
or approval of any other Investor or Key Holder;

 

(c)           if
any amendment, waiver, discharge or termination operates in a manner that treats any Investor or Key Holder materially differently
from other Investors or Key Holders, respectively, the consent of such Investor or Key Holder shall also be required for such amendment,
waiver, discharge or termination; and

 

(d)           the
consent of the Key Holders or Investors shall not be required for any amendment, waiver, discharge or termination if such amendment,
waiver, discharge or termination does not apply to the Key Holders or Investors, respectively.

 

Any
such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon the Company,
the Investors, the Key Holders and each future holder of shares of Preferred Stock with rights under this Agreement and their respective
successors and permitted assigns, whether or not such party, other shareholder, successor or assignee entered into or approved
such amendment, waiver, discharge or termination. Each Investor and Key Holder acknowledges that by the operation of this paragraph,
(i) the Company, (ii) Key Holders holding a majority of the Seller Shares (on an as-converted-to- common-stock basis)
held by all Key Holders, (iii) Investors holding a majority of the Common Stock issued or issuable upon conversion of the
Preferred Stock held by all Investors (excluding any of such shares that have been sold to the public or pursuant to Rule 144)
and permitted transferees will collectively have the right and power to diminish or eliminate the rights of such Investor or Key
Holder under this Agreement. If determined by a Special Board Vote (as defined in the Company’s certificate of incorporation),
the Company shall give prompt written notice of any amendment, waiver, discharge or termination hereunder to any party hereto that
did not consent in writing to such amendment, waiver, discharge or termination. For purposes of this Section 8.4, the
requirement of a written instrument may be satisfied in the form of an action by written consent of the Investors circulated by
the Company and executed by the parties specified.

 

8.5          Additional
Parties. Following the date of this Agreement, the Company agrees to use commercially reasonable efforts to cause each person
(other than an Investor) who comes to hold at least 1% of the shares of Common Stock (assuming full conversion of the Preferred
Stock and full conversion or exercise of all outstanding convertible securities, rights, options and warrants and all securities
reserved for issuance under the Company’s stock plans) to become a party to this Agreement and be deemed a “Key
Holder” hereunder and no amendment of this Agreement pursuant to this paragraph or any consent or approval of any other
Investor shall be required as a condition to such Key Holder’s execution and delivery of an additional counterpart signature
page to this Agreement.

 

    -11- 

     

    

 

8.6          Continuity
of Other Restrictions. Any Seller Shares not purchased by the Company or any Eligible Investor pursuant to their Right of
First Refusal hereunder will continue to be subject to all other restrictions imposed upon such Seller Shares hereunder and by
law, including any restrictions imposed under the Company’s certificate of incorporation or bylaws, or by agreement.

 

8.7          Governing
Law. This Agreement shall be governed in all respects by the internal laws of the State of New York as applied to agreements
entered into among New York residents to be performed entirely within New York, without regard to principles of conflicts of law.

 

8.8          Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that
execute such counterparts, and all of which together shall constitute one instrument.

 

8.9          Further
Assurances. Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company,
partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as
may be necessary to more fully effectuate this Agreement.

 

8.10        Conflict.
In the event of any conflict between the terms of this Agreement and the Company’s certificate of incorporation or its
bylaws, the terms of the Company’s certificate of incorporation or its bylaws, as the case may be, will control. In the
event of any conflict between the terms of this Agreement and any other agreement to which a Key Holder is a party or by which
such Key Holder is bound, the terms of this Agreement will control. In the event of any conflict between the Company’s books
and records and this Agreement or any notice delivered hereunder, the Company’s books and records will control absent fraud
or error.

 

8.11        Attorney’s
Fees. In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party
in such dispute shall be entitled to recover from the losing party such reasonable fees and expenses of attorneys and accountants,
which shall include, without limitation, all fees, costs and expenses of appeals.

 

8.12        Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs, exhibits and schedules
shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits and schedules attached hereto.

 

8.13        Entire
Agreement. This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between the parties
with regard to the subjects hereof and supersedes in its entirety the Prior Agreement, which shall have no further force and effect.
This Agreement shall be deemed an amendment and restatement of the Prior Agreement, and any party thereto who does not execute
and deliver this Agreement will nevertheless be deemed a party hereunder and have all of the rights, benefits and obligations
associated therewith. No party hereto shall be liable or bound to any other party in any manner with regard to the subjects hereof
or thereof by any warranties, representations or covenants except as specifically set forth herein.

 

    -12- 

     

    

 

8.14        Delays
or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to
any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power
or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default
be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval
of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of
any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.

 

8.15        Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties
and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on
behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all purposes.
At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any
facsimile, telecopy or other reproduction hereof.

 

8.16        Jurisdiction;
Venue. With respect to any disputes arising out of or related to this Agreement, the parties consent to the exclusive jurisdiction
of, and venue in, the state courts in New York County, New York (or in the event of exclusive federal jurisdiction, the courts
of the Southern District of New York).

 

8.17        Aggregation.
All shares of Preferred Stock of the Company held or acquired by affiliated entities or persons of an Investor (including
but not limited to: (i) a constituent partner or a retired partner of an Investor that is a partnership; (ii) a parent,
subsidiary or other affiliate of an Investor that is a corporation; (iii) an immediate family member living in the same household,
a descendant, or a trust, in the case of an Investor who is an individual; or (iv) a member of an Investor that is a limited
liability company) shall be aggregated together for the purpose of determining the availability of any rights under this Agreement
which are triggered by the beneficial ownership of a threshold number of shares of the Company’s capital stock.

 

8.18       Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS
AGREEMENT.

 

(signature page follows)

 

    -13-

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	FLY BLADE, INC.
	 	a Delaware corporation
	 	 	 
	 	By:	/s/
    Rob Wiesenthal

 

	 	Name:	Rob Wiesenthal
	 	 	 
	 	Title:	Chief Executive Officer

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	KEY HOLDER
	 	 
	 	Rob Wiesenthal
	 	(Print name of Key Holder)
	 	 
	 	/s/ Rob Wiesenthal
	 	(Signature)
	 	 
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	(Print title of signatory, if signing for an entity)

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	KEY HOLDER
	 	 
	 	JumpTen LLC
	 	(Print name of Key Holder)
	 	 
	 	/s/ Steve Martocci
	 	(Signature)
	 	 
	 	Steve Martocci
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	(Print title of signatory, if signing for an entity)

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	COLPE BLADE INVESTOR, LLC
	 	 	 
	 	By:	/s/ Mark M. Hedstrom

	 	 	 
	 	Name:	Mark M. Hedstrom
	 	 	 
	 	Title:	Vice President

 

(Signature page to the Amended and Restated Right
of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	LERER HIPPEAU VENTURES V, LP
	 	 	 
	 	By:	Lerer Hippeau Ventures V GP, LLC, its General Partner
	 	 	 
	 	By:	/s/ Eric Hippeau

	 	 	 
	 	Name:	Eric Hippeau
	 	 	 
	 	Title:	Managing Member

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

		INVESTOR
	 	 
	 	LERERHIPPEAUVENTURES
SELECT FUND,LP
	 	 
	 	By:	LererHippeauVenturesSelectFundGP,LLC,itsGeneralPartner    
	 	 
	 	By:	/s/EricHippeau    

	 	 
	 	Name:	EricHippeau
	 	 
	 	Title:	ManagingMember                                                          

 

(Signature page to
the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	Lerer Investments II, LLC
	 	(Print name of Key Holder)
	 	 
	 	/s/ Kenneth Lerer
	 	(Signature)
	 	 
	 	Kenneth Lerer
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	Managing Member
	 	(Print title of signatory, if signing for an entity)

 

(Signature page to
the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	Andrew Bazos
	 	(Print investor name)
	 	 
	 	/s/ Andrew Bazos
	 	(Signature)

 

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	Andrew Farkas
	 	(Print investor name)
	 	 
	 	/s/ Andrew Farkas

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	Gerald J. Cardinale
	 	(Print investor name)
	 	 
	 	/s/ Gerald J. Cardinale

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

		INVESTOR
	 	
	 	I-HATCH MANAGEMENT LLC
	 	
	 	By:	 /s/ Bradford Farkas

	 	 
	 	Name:	Bradford Farkas
	 	(Print investor name)
	 	
	 	Title:	Managing Member

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	MATTHEW JACOBSON TRUST UAD
	 	6/9/10
	 	 
	 	By:	/s/ Matthew Jacobson

	 	 
	 	Name:	Matthew Jacobson
	 	(Print investor name)
	 	 
	 	Title:	Trustee

 

(Signature page to
the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	PLYMOUTH TECHNOLOGY LLC
	 	 
	 	By: Plymouth Investment, LP, its Sole Member
	 	 
	 	By:	/s/ Richard Mishaan

	 	 
	 	Name:	Richard Mishaan
	 	(Print investor name)
	 	 
	 	Title:	Managing director

 

(Signature page to the Amended and Restated
Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	RAINE VENTURE PARTNERS LLP
	 	 
	 	By: Raine Venture Associates I LP, its general partner
	 	 
	 	By: Raine Management LLC, its general partner
	 	 
	 	By:	/s/ Alfred Chianese

	 	 
	 	Name:	Alfred Chianese
	 	(Print investor name)
	 	 
	 	Title:	Vice President
	 	 
	 	Address: 810 Seventh Ave, 39th Floor, New York NY 10019

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	Snickers Holdings LLC
	 	(Print name of Key Holder)
	 	 
	 	/s/ David Zaslav
	 	(Signature)
	 	 
	 	David Zaslav
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	President
	 	(Print title of signatory, if signing for an entity 

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	ROB WIESENTHAL
	 	 
	 	/s/ Rob Wiesenthal
	 	(Signature)

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

		INVESTOR
	 	
	 	AIRBUS HELICOPTERS S.A.S  
	 	 
	 	By:	/s/ Clive Schley   

	 	
	 	Name:	Clive Schley
	 	 
	 	Title:	SVP Strategy

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	LIONTREE PARTNERS LLC
	 	 
	 	By:	/s/ Matthew Derdeyn

	 	 
	 	Name:	Matthew Derdeyn
	 	 
	 	Title:	Chief Financial Officer

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

 

     

     

    

 

The parties are
signing this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	INVESTOR
	 	 
	 	JUST BLADE, LLC
	 	 
	 	By:	/s/ Mark M. Hedstrom

	 	 
	 	Name:	Mark M. Hedstrom
	 	 
	 	Title:	Vice President

 

(Signature
page to the Amended and Restated Right of First Refusal and Co-Sale Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]